WO1988008164A1 - Computer designed stabilized proteins and method for producing same - Google Patents

Computer designed stabilized proteins and method for producing same Download PDF

Info

Publication number
WO1988008164A1
WO1988008164A1 PCT/US1988/000849 US8800849W WO8808164A1 WO 1988008164 A1 WO1988008164 A1 WO 1988008164A1 US 8800849 W US8800849 W US 8800849W WO 8808164 A1 WO8808164 A1 WO 8808164A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
subtilisin
amino acid
disulfide bond
gly gly
Prior art date
Application number
PCT/US1988/000849
Other languages
French (fr)
Inventor
Michael W. Pantoliano
Robert Charles Ladner
Original Assignee
Genex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genex Corporation filed Critical Genex Corporation
Publication of WO1988008164A1 publication Critical patent/WO1988008164A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20Protein or domain folding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50Mutagenesis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Definitions

  • the present .invention pertains to protein molecules which possess enhanced stability and to nucleic acid sequences which encode such proteins. These proteins were designed for enhanced stability using a computer- assisted method.
  • the present invention provides a computer-assisted method for designing stable protein molecules.
  • Proteins are linear polymers of amino acids. Since the polymerization reaction which produces a protein results in the loss of one molecule of water from each amino acid, proteins are often said to be composed of amino acid "residues.” Natural protein molecules may contain as many as 20 different types of amino acid residues, each of which contains a distinctive, side chain. The particular sequence of amino acid residues in a protein defines the primary sequence of the protein. Proteins fold into a three-dimensional structure. The folding is determined by the sequence of amino acids and by the protein's environment. The remarkable properties of proteins depend directly from the protein's three-dimensional conformation. Thus, this conformation determines the activity or stability of enzymes, the capacity and specificity of binding proteins, and the structural attributes of receptor molecules. Because the three-dimensional structure of a protein molecule is so significant, it has long been recognized that a means for stabilizing a protein's three-dimensional structure would be highly desirable.
  • the three-dimensional structure of a protein may be determined in a " number of ways. Perhaps the best known way of determining protein structure involves the use of the technique of x-ray crystallography. An excellent general review of this technique can be found in Physical Bio-chemistrv. Van Holde, K.E. (Prentice-Hall, NJ (1971) pp221-239) which reference is herein incorporated by reference. Using this technique, it is possible to elucidate three-dimensional structure with remarkable precision. It is also possible to probe the three-dimensional structure of a protein using circular dichroism, light scattering, or by measuring the absorption and emission of radiant energy (Van Holde, Physical Biochemistry. Prentice-Hall, NJ (1971)).
  • protein structure may be determined through the use of the techniques of neutron defraction, or by nuclear magnetic resonance (Physical Chemistry, 4th Ed. Moore, w.J. , Prentice-Hall, NJ (1972) which reference is hereby incorporated by reference) .
  • the examination of the three-dimensional structure of numerous natural proteins has revealed a number of recurring patterns.
  • Alpha helices, parallel beta sheets, and anti-parallel beta sheets are the most common patterns observed.
  • An excellent description of such protein patterns is provided by Dickerson, R.E., e al. In: The Structure and Action of Proteins, .A. Benjamin, Inc., CA (1969).
  • the assignment of each amino acid to one of these patterns defines the secondary structure of the protein.
  • the helices, sheets and turns of a protein's secondary structure pack together to produce the three-dimensional structure of the protein.
  • the three-dimensional structure of many proteins may be characterized as having internal surfaces (directed away from the aqueous environment in which the protein is normally found) and external surfaces (which are in close proximity to the aqueous environment) .
  • hydrophobic residues such as tryptophan, phenylalanine, tyrosine, leucine, isoleucine, valine, or methionine
  • hydrophilic residues such as asparate, asparagine, glutamate, glutamine, lysine, arginine, histidine, serine, threonine, glycine, and proline
  • amino acids alanine, glycine, serine and threonine are encountered with equal frequency on both the internal and external protein surfaces.
  • Proteins exist in a dynamic equilibrium between a folded, ordered state and an unfolded, disordered state. This equilibrium in part reflects the interactions between the side chains of amino acid residues which tend to stabilize the protein's structure, and, on the other hand, those thermodynamic forces which tend to promote the randomization of the molecule.
  • the amino acid side chain interactions which promote protein folding and confer catalytic activity fall into two classes.
  • the interactions may be caused by weak forces (e.g., hydrogen bonds) between the side chains of different amino acid residues.
  • they may be caused by direct covalent bonding between the sulfhydryl groups of two cysteine amino acid residues. Such a bond is known as a "disulfide" bond.
  • any cysteine residues present contain free sulfhydryl groups (-SH) .
  • -SH free sulfhydryl groups
  • disulfide bonds -S—S-
  • This chemical bond is said to convert two "cysteine” residues into a "cystine” residue.
  • “cysteine” residues differ from a "cystine” residue in that the former molecules contain sulfur atoms which are cova- lently bonded to hydrogen, whereas the latter molecule contains a sulfur atom which is covalently bonded to a second sulfur atom.
  • a disulfide bond may stabilize the folded state of the protein relative to its unfolded state.
  • the disulfide bond accomplishes such a stabilization by holding together the two cysteine residues in close proximity. Without the disulfide bond, these residues would be in close proximity in the unfolded state only a small fraction of the time. This restriction of the conformational entropy (disorder) of the unfolded state destabilizes the unfolded state and thus shifts the equilibrium to favor the folded state.
  • the effect of the disulfide bond on the folded state is more difficult to predict. It could increase, decrease or have no effect on the free energy of the folded state. Increasing the free energy of the folded state may lead to a destabilization of the protein, which would tend to cause unfolding.
  • the cysteine residues which participate in a disulfide bond need not be located near to one another in a protein's primary amino acid sequence.
  • cysteine residues may be introduced into a protein: (1) through a replacement-exchange with one of the protein's normally occurring amino acid residues, or (2) an insertion of a cysteine between two existing amino acid residues.
  • One goal of the present invention is to provide a method for determining whether the active folded state of a protein would be stabilized by the presence of a disulfide bond between particular regions of the protein molecule.
  • the present invention accomplishes this goal -through the development of a novel method for selecting sites in natural proteins where the introduction of a novel disulfide linkage will have a high probability for stabilizing a particular protein.
  • the invention pertains to a method for evaluating a protein's structure to determine whether the protein contains at least two target amino acid residues, the replacement of at least one of which with a cysteine residue would be sufficient to permit the formation of at least one potentially protein-stabilizing disulfide bond; the method comprising the steps of:
  • the invention also pertains to a method for producing a protein having a potentially stabilizing disulfide bond which comprises:
  • the invention also includes the method of producing a stabilized protein molecule comprising:
  • the invention also includes a method for producing a protein having a potentially protein-stabilizing disulfide bond which comprises:
  • step (1) (2) examining any pair of amino acids found to contain the certain atoms identified in step (1) to determine whether the new atoms of a possible disulfide linkage can be accommodated without creating unacceptable steric hindrance
  • the invention additionally includes a protein of increased stability produced by the above method.
  • the invention further includes a nucleic acid sequence which encodes a protein of increased stability produced by the above method.
  • the invention provides a method for identifying possible sites within a protein molecule at which cysteine residues might be introduced to replace the normally present amino acid residues. These cysteine residues would then be permitted to form disulfide bonds with each other. By correctly selecting the sites for cysteine incorporation, these disulfide bonds determined by the invention will add to the stability of the folded active protein conformation.
  • the methods and proteins of the present invention are disclosed in co-pending, commonly assigned United States patent application Serial Number 034,966 , filed concurrently with this application by Pantoliano, M.W., et al. , which reference is hereby incorporated by reference.
  • the present invention provides a method for evaluating a protein's structure to determine whether the protein contains at least two target amino acid residues.
  • An amino acid residue is considered to be a "target” residue if its replacement with a cysteine residue would be sufficient to permit the formation of at least one potentially-stabilizing disulfide bond.
  • disulfide bond, disulfide linkage, and disulfide bridge are meant to be interchangeable, and equivalent.
  • An amino acid which is being evaluated to determine whether it may serve as a target amino acid residue is termed a "candidate target" amino acid residue.
  • any amino acid residue of protein may, thus, be considered as a "candidate target” amino acid residue; however, only certain amino acid residues will fulfill the requirements of a "target” residue.
  • the present invention employs a computer based method for determining and displaying possible sites within natural or engineered proteins where cysteine residues could be inserted to replace the naturally-occurring amino acid residue so that a disulfide linkage would form when the modified protein was mildly oxidized. If the original protein contains one cysteine suitably related to another amino acid, it may be sufficient to change only one amino acid to produce the novel disulfide linkage. In most cases, however, it will be necessary to introduce two cysteine residues into the engineered protein.
  • the original natural protein is referred to as the "wild-type protein-,"
  • the protein which contains the introduced cysteine residues is referred to as the "engineered protein.”
  • the terms “disulfide bridge”, “disulfide»bond”, and “cystine” are meant to be equivalent and to describe the structure formed from the disulfide bonding of two cysteine residues to one another.
  • disulfide bonds possess the capacity for stabilizing the folded state of a protein molecule, the presence of a disulfide bond does not control whether the bond will promote protein folding or unfolding. In order to determine the effect of a disulfide bond on protein structure, it is necessary to consider the effects of that bond on the free energy of the folded protein molecule and the unfolded protein molecule.
  • the free energy of a molecule is a thermodynamic measure of the conformation of a molecule. To increase the stability of a protein, one must either lower the free energy of the folded state, or raise the free energy of the unfolded state.
  • the free energy of a molecule is determined from the formula:
  • ⁇ G represents the free energy of protein unfolding (folded unfolded)
  • ⁇ H represents the change in enthalpy of reaction
  • T represents the temperature
  • L S represents the change in free entropy.
  • ⁇ _H exceeds the product of temperature and £S.
  • AG is a positive value and the folded _ state of the protein will predominate.
  • ⁇ G is less than zero, protein unfolding will predominate.
  • ⁇ .S may be accomplished by providing either more disorder within the folded state, or by decreasing the disorder of the unfolded state.
  • disulfide bonds may increase the stability of natural proteins by lowering the disorder of the unfolded protein state.
  • Amino acids that are distant in sequence would normally be free to be far apart in the unfolded state, but this freedom would be lost if the residues were linked by a disulfide bond.
  • the disulfide bond must not adversely affect AH or impose additional order on the folded state. This means that the disulfide bond must fit into the normal protein conformation without straining it.
  • the further the two' cysteines residues are from one another in the primary protein structure the greater will be the affect upon the ⁇ S.
  • linking two distant cysteine residues should destabilize the unfolded protein state much more than a similar linkage between two closely adjacent cysteine residues.
  • the invention may be operated on a conventional minicomputer system having storage devices capable of storing the Brookhaven protein data bank or an equivalent data base, various applications programs utilized by the invention, and the parameters of the possible candidates that are being evaluated.
  • the mini-computer CPU is connected by a suitable bus to an interactive computer graphics display system.
  • the interactive computer graphics display system comprises a display terminal with resident three- dimensional application software and associated input' and output devices, such as X-Y plotters, position control devices (potentiometers, an X-Y tablet, or a mouse) , and keyboard.
  • the interactive computer graphics display system allows an operator to view the chemical structures being evaluated in the design process of the invention. Graphics and programs are used to evaluate the possible conflicts between new disulfide bridges and retained atoms of the wild-type protein.
  • the first general step of the computer based method of the invention involves the compilation of a library of acceptable geometries which are defined by disulfide linkages between regions of protein main chain.
  • a library can be constructed from the Brookhaven Protein Data Bank (BPDB) (Brookhaven Protein Date Base, Chemis ⁇ try Dept., Brookhaven National Laboratory, Upton, NY 11973) or equivalent data bases.
  • BPDB Brookhaven Protein Data Bank
  • disulfide bridges there are cases in which two or more observed disulfide bridges can be superimposed to high degree of accuracy considering the atoms N, alpha C, beta C, and carbonyl C on each side of the disulfide bridge, but that the S atoms do not match at all well.
  • one disulfide bridge has CHI 3 near 90 degrees while the other has CHI3 near -90 degrees.
  • the geometry of the disulfide group is determined by the surrounding atoms.
  • the second general step of the computer based method of the invention involves examining each .pair of amino acid residues in the protein of interest to see if they contain certain atoms whose relative three- dimensional positions possess the same geometric conformation as the corresponding atoms of some known disulfide bridge. This examination is done automatically by the computer program, which evaluates the library prepared in the first general step of the present invention.
  • the atoms checked in this step are the main-chain nitrogen, the alpha carbon, the beta carbon, and the carbonyl carbon of the two amino acids of the selected pair. Within each amino acid, these four atoms form a pyramid with the alpha carbon at the apex and with no easily-changed internal degrees of freedom.
  • the computer program which implements the second general step is broken into two phases.
  • the first phase examines the distance between the centers-of-mass of the pyramids formed within each of the two amino acids of the selected pair. If the distance between the two centers-of-mass is greater than the largest known distance of any of the disulfide linkages in the library, or smaller than the smallest known distance of any of the disulfide linkages in the library, then the selected pair of residues is discarded and the next pair of residues is considered. Alternatively, if the distance between the centers-of-mass of the two residues fall within the range of inter-pyramid distances in the library then the second phase of the second general step is executed for this pair of residues.
  • the eigh1_ ⁇ - atoms forming the pyramids of the two residues in question are considered as a single group having eight three-dimensional coordinates.
  • the structure of> this 8-atom group is compared (according to the method of least squares) to each of the different disulfide bridges contained in the library.
  • the root-mean-squared (RMS) error for the fit of the selected amino acid pair .as compared to each different observed disulfide bond in the library is recorded in computer memory. If for at least one observed disulfide bridge, the RMS error falls below a preset limit then the residue pair in question is recorded as passing the second general step.
  • RMS root-mean-squared
  • This preset limit may vary between 0.3 - 0.6 A and is preferably set to a value within the range 0.4 - 0.5 A.
  • the current residue pair is rejected and the next pair is examined: For example, with a particular protein of 141 amino acids (such as for example ⁇ taphylococcal nuclease) , 387 amino acid- pairs will pass phase one of the second general step. However, only 27 sites will pass phase two of step two and thus be subject to further consideration. The number of sites to be tested will rise as the square of the number of amino acids which comprise the protein, however, the number of good candidates will rise only linearly with this number. The linear rise in the number of good candidates is a result of the limited number of close neighbors which any residue can have.
  • the sites listed in the second general step are examined by a computer program to see if the new atoms of the disulfide linkage can be accommodated without altering the tertiary conformation of the protein molecule.
  • the new sulfurs of the disulfide bond (to be incorporated into the protein molecule) are positioned according to the observed disulfide which matched best at the site in question in step two. If either or both of the wild-type amino acids are glycines, beta carbons are added as needed.
  • the distance between the sulfurs (and carbons, if new) and all nearby atoms are calculated and a list of distances shorter than physically reasonable (i.e., a list of possible steric contacts) is recorded.
  • This list is divided into two categories based upon the kind of interaction involved: interactions with main-chain atoms and interactions with side-chain atoms (the beta carbon is included as a main chain atom because it cannot be moved by rotation about the side-chain bonds) .
  • a separation distance at which a contact is taken as unreasonably short is set to some preset amount. This preset amount is smaller than the sum of the van der Waals radii of the atoms in question. This preset value is preferably between 0.4 - 0.6 A, however other values could be used.
  • the sites selected in step two are ordered according to the number of main-chain short contacts. If several sites have identical numbers of main-chain short contacts, these sites are ordered according to the number of side-chain short contacts.
  • all sites selected in general step two are passed through to step four with a notation of how many sterically unacceptable contacts exist in each category. An expert user reviews this list and excludes sites with excessive numbers of such contacts.
  • an expert operator uses an interactive three- dimensional computer graphics display to view each of the disulfide bond candidates and to rank them from those most likely to stabilize an engineered protein (relative to the wild-type protein) , -to those least likely to stabilize the protein. This ranking is done by considering:
  • sequences of proteins evolutionally related to the wild- type protein are used to discover which amino acids may be most easily altered without seriously reducing the stability of the protein. If many sequences are available for similar proteins from a variety of sources, it may be observed that certain residues are strongly conserved in evolution. This conservation will indicate that, in a given location, one particular amino acid is strongly preferred to give an active, stable protein. At many other locations, however, a plurality of amino acids may be acceptable. This information is used to further rank the candidates to determine which of the possible pairs of residues are most likely to give a stabilizing disulfide bridge.
  • those sites which involve no conserved amino acids are much more likely to give a stabilized disulfide bridge than a site which involves one conserved amino acid, which in turn is much more likely to give a stabilizing disulfide bridge than a site which involves two conserved amino acids.
  • the elected candidates provide potential sites at which pairs of cysteine residues may be introduced. Mild oxidation of the resulting engineered proteins will give rise to proteins containing disulfide bridges.
  • the method of selecting the sites described in general steps 1-5 makes it highly likely that the resulting engineered proteins will have the same tertiary structure and biological activity as the initial wild-type protein. Moreover, it is highly likely that the engineered proteins will be more stable with regard to agents which cause proteins to unfold (i.e., elevated temperature, altered pH, organic solvents, detergents, or chaotropic salts) .
  • the parameters of the candidates can be stored for later use. They can also be provided by the user either visually or recorded on a suitable medium (paper, magnetic tape, color slides, CRT, etc) .
  • the results of the various steps utilized in the analysis can be stored for later use or examination.
  • the present invention can be programmed so that certain expert rules are utilized to eliminate unsuitable candidates before they are presented to the operator. These expert rules can be modi ied based on experimental data as more proteins are modified by introduction of disulfide bridges, or as more natural proteins containing disulfide bridges are added to the data base used in general step one.
  • the present invention enables one to identify possible residues which, if replaced by cysteines, might result in the formation of a potentially protein stabilizing disulfide bond.
  • the above-described general steps of the invention may be performed manually, in a semi-automated process or more preferably with the aid of a computer.
  • the best mode for performing the general steps of the invention involves the use of a computer.
  • the computer-assisted method of the best mode is described in related, co-pending, commonly assigned U.S. patent application Serial No. 034,966 , filed concurrently with this application by Pantoliano, M.W. , et al. , which reference has been incorporated by refer ⁇ ence.
  • the Brookhaven Protein Data Bank contains structures for between 250 and 300 proteins. Many of these structures contain disulfide bridges. Because this - collection of structures has been obtained from many different laboratories over several years, there is substantial variation in the quality of structures. Most protein structures are refined against diffraction data subject to constraints or restraints. Many proteins do not diffract x-rays very well and consequently insufficient data exists to determine the position of each atom. Furthermore, until quite recently collection of protein diffraction data was very laborious so that crystallographers often did not collect all the data that could be collected.
  • Crystallographers generally assume that all bond distances and angles are the same as or very close to the distances and angles determined in small-molecule structures where every atom can be localized very accurately. These added data make it possible to construct models of proteins in which each non-hydrogen atom is represented by an x-y-z triplet plus an isotropic temperature factor.
  • the methods of the present invention utilize the geometric relationship between two amino acids which might be connected by a disulfide bridge, the most important point to determine about each reported disulfide bridge is whether the report is correct.
  • the eight main-chain atoms have 24 degrees of freedom.
  • Least-squares fitting of a standard pyramid (containing the nitrogen, carbonyl carbon, alpha carbon, and beta carbon of an amino acid) at each end filters out most of the noise in the report coordinates. Finally the six degrees of freedom relating the two standard pyramids are calculated.
  • the November 1986 release of BPDB contained 512 reported disulfide bridges.
  • disulfide linkages which departed from average distances by more than 10% were considered suspicious.
  • the data obtained from these structures may however still be useful, because all that is required is 1) that a disulfide bridge does, in fact, exist, and 2) the nature of the relationship between the two segments of main chain.
  • disulfide bridges with incorrect intersulfur distances are not simply rejected, rather attempts to impose correct internal geometry by small movements of the sulfur atoms (i.e., less than 0.2 A) or very small movements- of the beta carbons (less than 0.1A) are made.
  • the program compares each reported disulfide with all others to eliminate geometric duplicates. For this purpose, two disulfide bonds are considered the same if ten of their atoms can be superimposed on the corresponding atoms with an RMS error less than 0.2 A. Removal of duplicates reduced the original 512 reported disulfide bonds to 138 unique ones.
  • the pyramid formed from the nitrogen, alpha carbon, beta carbon and carbonyl carbon of the individual cysteines is examined. These 4 atoms have 12 coordinates, yet only 6 degrees of freedom.
  • the pyramids formed from both of the cysteine residues are evaluated as follows. The 8 atoms (of the two pyramids) are translated until one pyramidal cluster set of 4 atoms has its center of mass at the origin. The constellation of 8 atoms is then rotated so that the plane formed by the nitrogen, carbonyl carbon, and the beta carbon is parallel to the X-Y plane.
  • the alpha carbon is then positioned so as to have a positive Z coordinate (the other 3 atoms of the pyramid thus have the same negative Z coordinate) .
  • the pyramid is then rotated about the Z axis until the nitrogen atom has a zero Y coordinate. This defines the standard position for the cysteine residue.
  • the coordinates of this group are shown in Table 1.
  • the process for selecting sites to stabilize a protein is perferably conducted through the use of a computer.
  • the algorithm followed by this program is composed of six different steps.
  • a similar standard coordinate pyramid is produced for a second amino acid of the protein under investigation. This second amino acid is designated by the letter “L.”
  • an eight atom image is constructed from the N, C alpha, C beta, and C carbonyl of each of the two pyramids.
  • the computer program then scans the library of known disulfide linkages to find that linkage with the lowest RMS error between the eight atoms of the target protein and the corresponding eight atoms from a library entry.
  • the program then repeats its scan in order to identify a second best fit disulfide linkage, subject to the restriction that CHI 3 for the second best fit must differ from CHI 3 of the best fit by at least some preset amount, 20° in preferred embodiment. Both the best fit and second best fit are recorded and stored for future use.
  • the computer program then picks a next pair of amino acids by the same method as that used if the distance between pyramids had not been in range.
  • the protein, staphylococcal nuclease which has 141 amino acids contains 10,011 amino acid pairs. Of these, 387 were close enough to define a distance which was in the bounds of the disulfide linkages contained in the library.
  • the pair of amino acids being evaluated is tested in both the direction L to K and the direction K to L. This is necessary because the geometries of cystines do not have a two-fold rotational symmetry about the midpoint of the S—S bond.
  • the list of RMS errors is scanned to find that entry which produced the smallest error. If this smallest error is below the preset threshold (for example, 0.40 - 0.55 A, preferably 0.45 A), an external record is written. The list of RMS errors is then searched for a second best fit subject to the condition that the dihedral angle CHI 3 of the second-best fit must differ from the angle CHI 3 by at least some minimal preset amount (i.e., 15 — 25 degrees). This second-best fit is recorded if its RMS error falls below the preset threshold value.
  • the preset threshold for example, 0.40 - 0.55 A, preferably 0.45 A
  • the above-described computer program provides a list of potential disulfide linkages which may be used to connect two regions of a protein molecule in an effort to stabilize that molecule. If the group of potential linkages is small, it may be feasible for one to construct protein molecules which possess each of the identified disulfide bridges. If, however, the selected group of linkages is large, it may not be possible to produce " an entire set of engineered protein molecules. In such a situation, it is desirable to rank the identified disulfide bridges and to eliminate candidates which are less likely to provide a stabilizing influence on the protein of interest. 1. Elimination of Candidates Based Upon Considerations of Steric Interactions
  • the stable folding of proteins is dominated by the packing of hydrophobic groups against each other and away from the generally aqueous solvent. It is essential that the volume inside the protein be nearly filled and that polar or charged groups make appropriate interactions with each other or with the solvent molecules.
  • some water molecules are found inside the protein and form hydrogen bonds with oxygen or nitrogen atoms of the internal surface of the protein. Many carbon and sulfur atoms (and the hydrogen atoms covalently bound to these atoms) are found to be in van der Waals contact with other non- polar atoms. Proteins form such densely packed structures . because a tightly compressed protein structure allows greater volume to the water and thus increases the entropy of the solvent. Hence, protein structure is not predominantly the result of the very weak attractive van der Waals forces between the protein atoms. In natural proteins, atoms are never closer than their van der Waals radii contact because of repulsive forces.
  • the simplest selection process for potential disulfide bridges would be to place all the atoms in the candidate structures and to then calculate the interatomic separations between the atoms of the disulfide bridge and all the retained atoms of the native protein. Candidates in which two atoms appear to be closer than permitted would be rejected. This very simple method is not used for two reasons: (1) The recorded protein coordinates may contain errors.
  • a potential steric interference between the atoms is recorded only when the atoms are closer than their van der Waals radii by some preset amount (i.e., preferably 0.4 - 0.6 A).
  • Such contacts are divided into two classes which are separately evaluated.
  • the first considered class are those in which the potentially interfering atoms are members of the main-chain of the protein. Contacts with main-chain atoms are more serious because the motion needed to relieve any steric interference might seriously disrupt the tertiary structure of the protein.
  • conflicts between hypothetical disulfide bridge atoms and atoms in other side chains might be easily relieved through rotations about side- chain bonds. Because of these considerations, the beta carbon is considered a main-chain atom because it is not moved by rotations about any side-chain bond.
  • A21.3.WP 032387 unfavorable because this would create a large hole inside the protein. In contrast, conversion of leucine, isoleucine, or methionine into cysteine is only mildly unfavorable.
  • a tenet of evolution is that the replication of genes is not error-free. Each error in copying a gene potentially alters the meaning of the encoded message. Because the genetic code has redundancies, many copying errors are silent and do not result in a change in the amino acid sequence encoded by the gene. For example, a mutation which changes a codon sequence of AAG into the codon sequence AAA would not effect the amino acid sequence of the encoded protein (which would in both cases be the amino acid lysine) .
  • the primary amino acid sequence of a protein may be stored within the deoxyribonucleic acid (DNA) of a cell capable of producing that protein.
  • DNA deoxyribonucleic acid
  • the DNA may be altered by altering the DNA which encodes a particular protein, it is possible to change that protein's primary sequence.
  • it is possible to change a protein's amino acid sequence either directly (as by incorporating additional cysteine residues by synthetic or semi-synthetic methods) or indirectly (as by altering the DNA or RNA sequence which encodes that protein it is far more advantageous to alter the protein's amino acid sequence indirectly. Indirect means are preferred because (1) it is far easier to alter a DNA sequence than to alter a protein sequence, and (2) the capacity of DNA to self- replicate enables one to produce ah inexhaustible supply of the desired protein molecule.
  • RNA ribonucleic acid
  • the overall processes through which a DNA sequence is converted into a protein is often referred to as "gene expression.”
  • the expression of a DNA sequence requires that the sequence be "operably linked" to DNA sequences which contain transcriptional and translational regulatory information.
  • An operable linkage is a linkage in which the regulatory DNA sequences and the sequences sought to be expressed are connected in such a way as to permit gene expression.
  • the regulatory DNA sequences involved in gene expression are termed "promoters.”
  • promoter refers to a region of regulatory DNA sequence which is recognized by a cell as a site adjacent to which to begin the initiation of the transcription of DNA into RNA.
  • Examples of promoters from prokaryotic cells or from viruses ' which infect prokaryotic cells include the E. coli recA, lac, and trp promoters (Shirakawa, M. et al. , Gene, 2 . 8:127-132 (1984)) or the left promoter of bacteriophage lambda (P_.) (Devare, S . G . , et al. Cell, 16_:43-49 (1984)).
  • promoters from eukary- otic cells or from viruses which infect such cells include the promoter of the mouse metallothionein I gene (Ha er, D. , et al. , J. Mol. Appl. Gen. 1:273-288 (1982)); the TK Promoter of Herpes, virus (McKnight, S., Cell 31:355-365 (1982)); and the SV40 early promoter (Benoist, C. et al.. Nature, 290:304-310 (1981)).
  • a genetic sequence which encodes that protein is operably linked to a promoter region, and introduced into a suitable cell (such as E. coli, Bacilles, yeast, or mammalian cells) .
  • a DNA sequence may be introduced into a cell by any of several means: transduction, transformation, conjugation, or microinjection, although it is most preferable to use transformation (Botstein, D. , et al. , The Molecular Biology of the Yeast Saccharomyces: Metabolism and Gene Expression, Cold Spring Harbor, N. Y., HB:607-636 (1982); Struhl, K. , Nature, 305:391-397 (1983); Bollon, A. P., et al. , J.
  • a plasmid is a covalently closed circular extrachromosomal nucleic acid molecule.
  • a plasmid contains two elements: (1) An origin of replication sufficient to permit the propagation of the plasmid in a host cell; and (2) a selectable marker sequence, preferably a gene whose expression confers an antibiotic resistance to the host cell, sufficient to enable the maintenance of the plasmid within the host cell and to facilitate the manipulation and introduction of the plasmid into new host cells.
  • the engineered proteins of the present invention by manipulating the DNA sequences which encode those proteins.
  • the manipulated DNA is then preferably incorporated into a plasmid molecule and introduced into a host cell which is capable of expressing such sequences, thereby producing the engineered protein molecule.
  • M13 or one of its derivatives, is converted to its single strand form, and incubated in the presence of the synthetic oligonucleotide. Since the DNA of the oligonucleotide is controllably defined, it is possible to construct an oligonucleotide capable of pairing with a complementary DNA sequence present on the single stranded plasmid. Once base pairing has occurred between the oligonucleotide and the single stranded plasmid, it is possible to extend the oligonucleotide using DNA polymerase to create a double stranded DNA molecule which may then be sealed by DNA ligase.
  • a wild-type protein contains the amino acid sequence lysine-serine-leucine
  • the corresponding DNA sequence might be AAA-TCT-CTT.
  • AAA-TGT-CTT a DNA sequence such as AAA-TGT-CTT.
  • Serine proteases are proteolytic enzymes which have a serine residue at their active site. Many species of bacteria are known to secrete such serine proteases into the culture medium. Serine proteases can be inhibited by ph e n y 1 m e th a n e s u 1 f o ny 1 f 1 o r i de and/or disopropylfluorophosphate.
  • Subtilisin is a serine protease produced by Gram positive bacteria and fungi. The amino acid sequences of seven different subtilisins are known. These include five subtilisins (SBT) from Gram positive bacteria of the genus, Bacillus.
  • SBT BPN' Bacillus amylolicruifaciens
  • the wild type SBT BPN' enzyme is discussed by Vasantha, et al. (J. Bacteriol. , 159: 811- 819 (1984) .
  • the three-dimensional structure of SBT BPN' has been determined to a resolution of 1.3 A.
  • V165 K170 0.41 0 2 145
  • the next two columns list the short contacts that occur between main or side-chain atoms (Short M/C; Short S/C) and thus provide an indication of the number of potential points of steric hindrance which are predicted to be present in the engineered protein.
  • the final column of Table 2 provides the CHI 3 angle of the bond in degrees.
  • subtilisins from several Bacillus strains have been purified and sequenced, it is possible to compare these sequences and thereby identify conserved amino acid residues. In performing this comparison, the following references were employed: SBT BPN 1 (Vasantha et al . , J . Bacteriol .
  • the amino acid sequence of the subtilisin thermitase from Thermoactmomyces vulgaris is also known (Meloun et al ⁇ , FEBS Lett. 183:195-200 (1985)).
  • the amino acid sequences from two fungal serine proteases are also partially known: proteinase K (Jany et al. , Biol. Chem. Hoppe-Seyler 366: 485-492 (1985)) and thermomycolase (Gaucher et al . , Methods Enzymol. 5.:415-433 (1976)).
  • subtilisin BPN' subtilisin BPN'
  • x-ray crystallographic data McPhalen et al. , FEBS Lett. 188:55-58 (1985) and Pahler et al.. EMBO J. 2:1311-1314 (1984)
  • a comparison of subtilisin amino acid sequences is shown in Table 4.
  • Sequences 1-5 are from bacilli.
  • T22:S87, Y26:L235, M50:N109, and Q206:A216 were selected for oligonucleotide-directed mutagenesis, and the variant proteins containing these selected disulfide bridges were called subtilisin 7159, 7157, 7168, and 8307, respectively.
  • strain GX7157 was constructed.
  • the SBT BPN' protein contains cysteine residues at position 26 (replacing valine) and at position 235 (replacing leucine) .
  • Strain GX7157 was found to be capable of producing and secreting subtilisin. The disulfide bond may have formed, but the resultant protein was decidedly less stable than wild-type. It was observed that the " single substitution of a cysteine for the lysine residue at position 235 was mildly destabilizing. In contrast, the engineered protein which possessed a cysteine instead of a valine at position 26 was approximately as stable as the wild-type protein.
  • a second mutant strain was constructed which contained cysteines at position 50 (replacing methionine) and position 109 (replacing asparagine) .
  • This mutant strain was designated GX7168.
  • Subtilisin was produced in this strain and secreted, however, the engineering protein was decidedly less stable than wild- type.
  • a third mutant strain was constructed in which the threonine at position 22 and the serine at position 87 were replaced by cysteines. This mutant was designated GX7159.
  • the subtilisin secreted by this strain was found to contain the desired disulfide bond. This engineered protein was decidedly more stable than wild- type subtilisin.
  • subtilisin 7159 In 10 mM calcium chloride, the rate for thermal inactivation of subtilisin 7159 (i.e., produced from mutant strain GX7159) is 1.1 times slower than wild-type subtilisin BPN 1 at 65°C. In 1 mM EDTA, the rate of thermal inactivation at 45"C for subtilisin 7159 is 1.5 to 2.0 times slower than that for wild-type subtilisin BPN'. It is well known that subtilisin is stabilized by free calcium ions. Many preparations for washing clothes contain agents to sequester calcium because free calcium interferes with the action of detergents. Thus the improved stability of subtilisin 7159 in a calcium-free environment (i.e. , an environment containing EDTA) is especially useful.
  • a calcium-free environment i.e. , an environment containing EDTA
  • subtilisin 7159 was melted in a differential scanning calorimeter. In 10 mM calcium chloride, subtilisin 7159 melted 0.5°C above the melting temperature of wild-type subtilisin. In 10 mM EDTA, subtilisin 7159 melted 3.1°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 7159 was substantially more thermodynamically stable than the wild-type protein.
  • a mutant was constructed which contained cysteine residues at position 206 (replacing glutamine) and at position 216 (replacing alanine) .
  • This mutant was designated GX8307.
  • the subtilisin secreted by this mutant was found to contain the desired disulfide bond.
  • the subtilisin produced by GX8307 was decidedly more stable than wild-type subtilisin.
  • subtilisin 8307 In 10 mM calcium chloride, the rate for thermal in ⁇ activation at 65°C for subtilisin 8307 is 1.1 times slower than that of wild-type subtilisin BPN' . In 1 mM EDTA, the rate of thermal inactivation at 45°C for subtilisin 8307 is also 1.5 to 2.0 times slower than wild-type subtilisin BPN' . In addition, subtilisin 8307 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 8307 melted about 3.0°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 8307 was substantially more stable than the wild-type protein. Since, as indicated above, subtilisin is stabilized by free calcium ions, the improved stability of subtilisin 8307 in a calcium-free environment is again especially useful for an enzyme to be introduced into detergents for washing clothes.
  • subtilisin 7159 (cysteines at positions 22 and 87) was combined in the same subtilisin molecule with a stabilizing mutation (asparagine 218 to serine) identified by random mutagenesis.
  • a stabilizing mutation asparagine 218 to serine
  • This new subtilisin molecule (subtilisin 7181) , which was secreted by strain GX7181, contained the desired disulfide bond and was decidedly more stable than wild- type.
  • Subtilisin 7181 was crystallized isomorphously to wild-type subtilisin. Using these crystals, x-ray data was collected to a resolution of 1.8 A. The phases of wild-type subtilisin were used to initiate Hendrickson- Konnert refinement (Hendrickson, W.H. and Konnert, J.H. (1980) In: Computing in Crystallography, (Diamond, R. , Ranseshan, S. and Venkatesan, K. , eds.), pp. 13.01- 13.23, Indian Institute of Science, Bangalore) which was continued until the crystallographic R index was 14.5. The disulfide bridge was found to be in the predicted conformation.
  • subtilisin 7181 In 10 M calcium chloride, the rate of thermal inactivation of subtilisin 7181 is 4.0 times slower than that of wild-type subtilisin BPN' at 65°C. In 1 mM EDTA, the rate of thermal inactivation at 45°C for subtilisin produced by GX7181 is approximately 5.2 times slower than that of wild-type subtilisin BPN 1 . In addition, subtilisin 7181 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 7181 melted 7.5°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 7181 was substantially more stable than the wild-type protein. Thus, the subtilisin produced by GX7181, which exhibits improved stability in a calcium-free environment, is especially useful in preparations which contain detergents.
  • subtilisin 8310 produced by strain GX8310, was found to be secreted and to contain both of the desired disulfide bonds. Subtilisin 8310 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 8310 melted about 5.5°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 8310 was substantially more stable than the wild-type protein.
  • Residues Val 26 and Leu 235 which are changed to cysteines in subtilisin 7157 are less variable than many of the other residues listed in Table 5, especially when compared with those involved in the disulfide linkages of 22/87 and 206/216.
  • Residues 26 and 235 are absolutely conserved within the Bacillus genus, and differ only in the thermitase sequence from Thermoactmomyces. These residues are decidedly more hydrophobic than those comprising the disulfide linkages in subtilisin 7159 and 8307.
  • °Ihe sequence hcroology is designated as nonconserved (NC) and absolutely conserved (AC) relative to the six sequences given in Table 4.
  • NC nonconserved
  • AC absolutely conserved
  • This linkage which was introduced into subtilisin 7140, has two residues that are absolutely conserved in the six sequences given in Table 4.
  • the decreased stability associated with this protein is believed to be due to altering important interactions that have been conserved throughout evolution.
  • subtilisin 7136, 7122, 7115, and 7124 also contain disulfide linkages that involve the alteration of a conserved residue, and all of these, except 7136, have also been found to have decreased stability relative to the wild- type protein.
  • These proteins however, also have the highest RMS errors, so the reason for the observed decreased stability is not so apparent in these cases. It could derive from a combination of a poor fit (RMS error) and alteration of a conserved interaction.
  • subtilisin 7127 and 7123 The two proteins that contain disulfide bridges that are not comprised of conserved residues are subtilisin 7127 and 7123. These linkages also do not have too bad a fit (RMS error of 0.48 and 0.51, respectively) . Both proteins were found to have stabilities close to that of the wild-type protein. The. failure of the 24/87 linkage to stabilize subtilisin 7123 may be related to the poor short contacts noted in the table. The 1/78 linkage is complex because of the relatively high accessibility of the N-terminus. Complex thiol chemistry which included intermolecular crosslinking was found to occur for subtilisin 7127.
  • subtilisin BPN' has been used as an active ingredient in detergent formulations for the enhancement of detergent performance.
  • Subtilisin-like proteases are currently used in detergent formulations to improve the removal of protein stains such as blood and milk from soiled fabrics or garments.
  • These detergent formulations can often present conditions of pH, temperature, free metal ion concentrations, and detergent content (hydrophobicity) that do not favor the properly folded state of enzymes, i.e., subtilisin-like proteases. Therefore, the present invention provides protein enzymes of enhanced stability that may be used in these applications.

Abstract

The invention pertains to a method for identifying amino acid residues in a protein which may be replaced with cysteine to permit the formation of potentially protein-stabilizing disulfide bonds. The invention also includes the stabilized proteins obtained through application of this method and nucleic acid molecules which encode such proteins.

Description

COMPU E DESIGNED STABILIZED PROTEINS AND METHOD FOR PRODUCING SAME
BACKGROUND OF THE INVENTION
The present .invention pertains to protein molecules which possess enhanced stability and to nucleic acid sequences which encode such proteins. These proteins were designed for enhanced stability using a computer- assisted method.
1. Field of the Invention
The present invention provides a computer-assisted method for designing stable protein molecules.
2. Related Art
Proteins (or polypeptides) are linear polymers of amino acids. Since the polymerization reaction which produces a protein results in the loss of one molecule of water from each amino acid, proteins are often said to be composed of amino acid "residues." Natural protein molecules may contain as many as 20 different types of amino acid residues, each of which contains a distinctive, side chain. The particular sequence of amino acid residues in a protein defines the primary sequence of the protein. Proteins fold into a three-dimensional structure. The folding is determined by the sequence of amino acids and by the protein's environment. The remarkable properties of proteins depend directly from the protein's three-dimensional conformation. Thus, this conformation determines the activity or stability of enzymes, the capacity and specificity of binding proteins, and the structural attributes of receptor molecules. Because the three-dimensional structure of a protein molecule is so significant, it has long been recognized that a means for stabilizing a protein's three-dimensional structure would be highly desirable.
The three-dimensional structure of a protein may be determined in a "number of ways. Perhaps the best known way of determining protein structure involves the use of the technique of x-ray crystallography. An excellent general review of this technique can be found in Physical Bio-chemistrv. Van Holde, K.E. (Prentice-Hall, NJ (1971) pp221-239) which reference is herein incorporated by reference. Using this technique, it is possible to elucidate three-dimensional structure with remarkable precision. It is also possible to probe the three-dimensional structure of a protein using circular dichroism, light scattering, or by measuring the absorption and emission of radiant energy (Van Holde, Physical Biochemistry. Prentice-Hall, NJ (1971)). Additionally, protein structure may be determined through the use of the techniques of neutron defraction, or by nuclear magnetic resonance (Physical Chemistry, 4th Ed. Moore, w.J. , Prentice-Hall, NJ (1972) which reference is hereby incorporated by reference) .
The examination of the three-dimensional structure of numerous natural proteins has revealed a number of recurring patterns. Alpha helices, parallel beta sheets, and anti-parallel beta sheets are the most common patterns observed. An excellent description of such protein patterns is provided by Dickerson, R.E., e al. In: The Structure and Action of Proteins, .A. Benjamin, Inc., CA (1969). The assignment of each amino acid to one of these patterns defines the secondary structure of the protein. The helices, sheets and turns of a protein's secondary structure pack together to produce the three-dimensional structure of the protein. The three-dimensional structure of many proteins may be characterized as having internal surfaces (directed away from the aqueous environment in which the protein is normally found) and external surfaces (which are in close proximity to the aqueous environment) . Through the study of many natural proteins, researchers have discovered that hydrophobic residues (such as tryptophan, phenylalanine, tyrosine, leucine, isoleucine, valine, or methionine) are most frequently found on the internal surface of protein molecules. In contrast, hydrophilic residues (such as asparate, asparagine, glutamate, glutamine, lysine, arginine, histidine, serine, threonine, glycine, and proline) are most frequently found on the external protein surface. The amino acids alanine, glycine, serine and threonine are encountered with equal frequency on both the internal and external protein surfaces.
Proteins exist in a dynamic equilibrium between a folded, ordered state and an unfolded, disordered state. This equilibrium in part reflects the interactions between the side chains of amino acid residues which tend to stabilize the protein's structure, and, on the other hand, those thermodynamic forces which tend to promote the randomization of the molecule.
The amino acid side chain interactions which promote protein folding and confer catalytic activity fall into two classes. The interactions may be caused by weak forces (e.g., hydrogen bonds) between the side chains of different amino acid residues. Alternatively, they may be caused by direct covalent bonding between the sulfhydryl groups of two cysteine amino acid residues. Such a bond is known as a "disulfide" bond.
When a protein is synthesized, any cysteine residues present contain free sulfhydryl groups (-SH) . When two sulfhydryl groups in close proximity are mildly oxidized, disulfide bonds (-S—S-) may form, thereby crosslinking the polypeptide chain. The formation of this chemical bond is said to convert two "cysteine" residues into a "cystine" residue. Thus "cysteine" residues differ from a "cystine" residue in that the former molecules contain sulfur atoms which are cova- lently bonded to hydrogen, whereas the latter molecule contains a sulfur atom which is covalently bonded to a second sulfur atom.
A disulfide bond may stabilize the folded state of the protein relative to its unfolded state. The disulfide bond accomplishes such a stabilization by holding together the two cysteine residues in close proximity. Without the disulfide bond, these residues would be in close proximity in the unfolded state only a small fraction of the time. This restriction of the conformational entropy (disorder) of the unfolded state destabilizes the unfolded state and thus shifts the equilibrium to favor the folded state. The effect of the disulfide bond on the folded state is more difficult to predict. It could increase, decrease or have no effect on the free energy of the folded state. Increasing the free energy of the folded state may lead to a destabilization of the protein, which would tend to cause unfolding. Importantly, the cysteine residues which participate in a disulfide bond need not be located near to one another in a protein's primary amino acid sequence.
One potential way of increasing the stability of a protein is to introduce new disulfide bonds into that protein. Thus, one potential application of recombinant DNA technology to the stabilization of proteins involves the introduction of cysteine residues to produce intraprotein disulfide bonds. There are two ways in which cysteine residues may be introduced into a protein: (1) through a replacement-exchange with one of the protein's normally occurring amino acid residues, or (2) an insertion of a cysteine between two existing amino acid residues.
Although the principles of recombinant DNA technology permit the introduction of new cysteine residues into a protein, they do not provide the researcher with any suggestion of where the introduced cysteine residues of the disulfide bond should be placed, or which amino acid(s) should be exchanged by such a replacement. Because of the substantial size and complexity of protein molecules, an evaluation of potential sites for disulfide bond linkages is exceedingly complex. Recently, investigators have employed computers and computer graphics displays as an aid for assessing the appropriateness of potential linkage sites (Perry, L.J. , & Wetzel, R. , Science, 226:555-557 (1984); Pabo, CO., et al. , Biochemistry, 25.:5987-5991 (1986); Bott, R. , et al. , European Patent Application Serial Number 130, 756; Perry, L.J., & Wetzel, R. , Biochemistry, 25^:733-739 (1986); Wetzel, R.B., European Patent Application Serial Number 155,832). The methods developed by Wetzel and co- workers permit one to project the three-dimensional conformation of a protein onto a computer screen and to simulate the effect which a disulfide bond might have on the protein's structure. Although these methods facilitate the design of more stable proteins, the researcher must still select the amino acid residues which are to be replaced by the cysteine residues of the disulfide bond. Hence, a substantial amount of guess work and trial and error analysis are still required. A need, therefore, still exists where a method which will assist the user in selecting potential disulfide bond linkage sites.
SUMMARY OF THE INVENTION
One goal of the present invention is to provide a method for determining whether the active folded state of a protein would be stabilized by the presence of a disulfide bond between particular regions of the protein molecule. The present invention accomplishes this goal -through the development of a novel method for selecting sites in natural proteins where the introduction of a novel disulfide linkage will have a high probability for stabilizing a particular protein. In detail, the invention pertains to a method for evaluating a protein's structure to determine whether the protein contains at least two target amino acid residues, the replacement of at least one of which with a cysteine residue would be sufficient to permit the formation of at least one potentially protein-stabilizing disulfide bond; the method comprising the steps of:
(a) comparing the distance between the centers-of-mass of two candidate target amino acid residues with the distance between the centers-of-mass of the cysteine residues of a disulfide bond;..
(b) calculating the error obtained when a known disulfide bond is superimposed on the two candidate target amino acid residues; and
(c) using the comparisons (a) and (b) to determine whether the protein contains the at least two target amino acid residues, the replacement of at least one of which with a cysteine residue is sufficient to permit the formation of a potentially protein- stabilizing disulfide bond.
The invention also pertains to a method for producing a protein having a potentially stabilizing disulfide bond which comprises:
(a) using the above-described method to identify at least one target amino acid residue of the protein which could be replaced by a cysteine residue thereby permitting the formation of a potentially protein-stabilizing disulfide bond, and
(b) producing a protein molecule wherein the identified target amino acid residue has been replaced with a cysteine residue, the replacement permitting the formation of the potentially protein-stabilizing disulfide bond.
The invention also includes the method of producing a stabilized protein molecule comprising:
(a) using the above-described method to identify at least one target amino acid residue of the protein which could be replaced by a cysteine residue thereby permitting the formation of a potentially protein-stabilizing disulfide bond,
(b) producing a protein molecule wherein the identified target amino acid residue has been replaced with a cysteine residue, the replacement permitting the formation of the potentially protein-stabilizing disulfide bond, and
(c) forming the disulfide bond.
The invention also includes a method for producing a protein having a potentially protein-stabilizing disulfide bond which comprises:
(a) using a computer based method to evaluate the protein's structure to determine whether the protein contains at least two target amino acid residues, the replacement of at least one of which with a cysteine residue would be sufficient to permit the formation of at least one potentially protein-stabilizing disulfide bridge; the method comprising the steps:
(1) examining each selected pair of amino acids in the protein to determine if they contain certain atoms whose relative three-dimensional positions possess a geometric conformation similar to the corresponding atoms of a known disulfide bridge,
(2) examining any pair of amino acids found to contain the certain atoms identified in step (1) to determine whether the new atoms of a possible disulfide linkage can be accommodated without creating unacceptable steric hindrance,
(3) permitting an expert operator (i) to view any possible disulfide linkage which can be accommodated without altering the tertiary conformation of the protein molecule, and (ii) to rank the viewed possible disulfide linkages from most likely to stabilize an engineered protein, to least likely to stabilize the protein, and
(4) evaluating the ranked proteins according to expert rule criterion; and
(b) producing a protein molecule wherein at least one of the target amino acid residues has been replaced by a cysteine residue, the replacement permitting the formation of a potentially protein- stabilizing disulfide bond.
The invention additionally includes a protein of increased stability produced by the above method.
The invention further includes a nucleic acid sequence which encodes a protein of increased stability produced by the above method.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
TABLE OF CONTENTS
I. BRIEF OVERVIEW OF THE INVENTION
A. Thermodynamic Considerations
B. The Five General Steps of the Invention
1. The First General Step
2. The Second General Step
3. The Third General Step
4. The Fourth General Step
5. The Fifth General Step
II. THE INVENTION IN DETAIL
A. The Five General Steps of the Invention
B. The Preparation of the Library of Disulfide Linkages
C. The Selection of Sites to Stabilize a Protein
D. The Elimination of Potential Candidates
1. Elimination of Candidates Based Upon Considerations of Steric Interactions
2. Elimination of Candidates Based Upon Considerations of Sequence Conservation
E. Recombinant DNA Manipulations
1. Production of Engineered Proteins
2. Production of Engineered Proteins by in vitro Mutagenesis of DNA
I. BRIEF OVERVIEW OF THE INVENTION
The invention provides a method for identifying possible sites within a protein molecule at which cysteine residues might be introduced to replace the normally present amino acid residues. These cysteine residues would then be permitted to form disulfide bonds with each other. By correctly selecting the sites for cysteine incorporation, these disulfide bonds determined by the invention will add to the stability of the folded active protein conformation. The methods and proteins of the present invention are disclosed in co-pending, commonly assigned United States patent application Serial Number 034,966 , filed concurrently with this application by Pantoliano, M.W., et al. , which reference is hereby incorporated by reference.
The present invention provides a method for evaluating a protein's structure to determine whether the protein contains at least two target amino acid residues. An amino acid residue is considered to be a "target" residue if its replacement with a cysteine residue would be sufficient to permit the formation of at least one potentially-stabilizing disulfide bond. As used herein, the terms disulfide bond, disulfide linkage, and disulfide bridge are meant to be interchangeable, and equivalent. An amino acid which is being evaluated to determine whether it may serve as a target amino acid residue is termed a "candidate target" amino acid residue. Any amino acid residue of protein may, thus, be considered as a "candidate target" amino acid residue; however, only certain amino acid residues will fulfill the requirements of a "target" residue. To accomplish the above-described goals, the present invention employs a computer based method for determining and displaying possible sites within natural or engineered proteins where cysteine residues could be inserted to replace the naturally-occurring amino acid residue so that a disulfide linkage would form when the modified protein was mildly oxidized. If the original protein contains one cysteine suitably related to another amino acid, it may be sufficient to change only one amino acid to produce the novel disulfide linkage. In most cases, however, it will be necessary to introduce two cysteine residues into the engineered protein. The original natural protein is referred to as the "wild-type protein-," In contrast, the protein which contains the introduced cysteine residues is referred to as the "engineered protein." The terms "disulfide bridge", "disulfide»bond", and "cystine" are meant to be equivalent and to describe the structure formed from the disulfide bonding of two cysteine residues to one another.
A. Thermodynamic Considerations
Although disulfide bonds possess the capacity for stabilizing the folded state of a protein molecule, the presence of a disulfide bond does not control whether the bond will promote protein folding or unfolding. In order to determine the effect of a disulfide bond on protein structure, it is necessary to consider the effects of that bond on the free energy of the folded protein molecule and the unfolded protein molecule.
The free energy of a molecule is a thermodynamic measure of the conformation of a molecule. To increase the stability of a protein, one must either lower the free energy of the folded state, or raise the free energy of the unfolded state. The free energy of a molecule is determined from the formula:
ΔG = ΔH - T(AS)
where ΔG represents the free energy of protein unfolding (folded
Figure imgf000015_0001
unfolded) , ΔH represents the change in enthalpy of reaction, T represents the temperature, and L Srepresents the change in free entropy. At low temperature, the value Λ_H exceeds the product of temperature and £S. Thus AG is a positive value and the folded _ state of the protein will predominate. In contrast, as the temperature is raised the product of temperature and free entropy eventually exceeds the value of ΔH and causes &G to become a negative number. When ΔG is less than zero, protein unfolding will predominate. Thus, if one could decrease the value of ΔS the folded state would be more stable even at higher temperatures. Lowering Δ.S may be accomplished by providing either more disorder within the folded state, or by decreasing the disorder of the unfolded state.
The introduction of disulfide bonds may increase the stability of natural proteins by lowering the disorder of the unfolded protein state. Amino acids that are distant in sequence would normally be free to be far apart in the unfolded state, but this freedom would be lost if the residues were linked by a disulfide bond. For this linkage to actually stabilize the folded state, the disulfide bond must not adversely affect AH or impose additional order on the folded state. This means that the disulfide bond must fit into the normal protein conformation without straining it. Importantly, the further the two' cysteines residues are from one another in the primary protein structure, the greater will be the affect upon the ΔS. Thus, linking two distant cysteine residues should destabilize the unfolded protein state much more than a similar linkage between two closely adjacent cysteine residues.
The invention may be operated on a conventional minicomputer system having storage devices capable of storing the Brookhaven protein data bank or an equivalent data base, various applications programs utilized by the invention, and the parameters of the possible candidates that are being evaluated.
The mini-computer CPU is connected by a suitable bus to an interactive computer graphics display system. Typically, the interactive computer graphics display system comprises a display terminal with resident three- dimensional application software and associated input' and output devices, such as X-Y plotters, position control devices (potentiometers, an X-Y tablet, or a mouse) , and keyboard.
The interactive computer graphics display system allows an operator to view the chemical structures being evaluated in the design process of the invention. Graphics and programs are used to evaluate the possible conflicts between new disulfide bridges and retained atoms of the wild-type protein.
B. The Five General Steps of the Computer Based Method
It is initially necessary to select a particular protein molecule whose enhanced stability is desired. The three-dimensional structure of the protein molecule is determined by means known in the art. Once this structure has been ascertained it is possible to employ the novel method of the present invention.
1. The First General Step
The first general step of the computer based method of the invention involves the compilation of a library of acceptable geometries which are defined by disulfide linkages between regions of protein main chain. Such a library can be constructed from the Brookhaven Protein Data Bank (BPDB) (Brookhaven Protein Date Base, Chemis¬ try Dept., Brookhaven National Laboratory, Upton, NY 11973) or equivalent data bases.
To produce such a library one ascertains the bond distances and bond angles associated with all atoms of the two cysteine residues of disulfide bonds which are present in proteins whose three-dimensional structure has previously been elucidated. Each entry of this library must have acceptable bond distances and bond angles, and must differ in internal geometry from all other entries in the library. The construction of this library need' not be repeated unless the library is to be enlarged.
For each disulfide bond entered into the library, it is necessary to record the positions of all 14 non- hydrogen atoms of the disulfide bonds (seven from each cysteine; main chain N, alpha C, beta C, S, carbonyl C, carbonyl O, and N of next residue) . From these coordinates, one can calculate the dihedral angle along the bond which joins the two sulfur atoms. This angle is called "CHI3" (CHI3 as used in this application arbitrarily has the opposite sign from the usual CHI3 defined in the literature, i.e., 244° = 116°). Such bond angles are referred to as the "characterizing" bond angles of a disulfide bond.
It has been noted by the inventors that there are cases in which two or more observed disulfide bridges can be superimposed to high degree of accuracy considering the atoms N, alpha C, beta C, and carbonyl C on each side of the disulfide bridge, but that the S atoms do not match at all well. In such cases, one disulfide bridge has CHI3 near 90 degrees while the other has CHI3 near -90 degrees. When the main-chain atoms are in such a relationship, the geometry of the disulfide group is determined by the surrounding atoms.
2. The Second General Step
The second general step of the computer based method of the invention involves examining each .pair of amino acid residues in the protein of interest to see if they contain certain atoms whose relative three- dimensional positions possess the same geometric conformation as the corresponding atoms of some known disulfide bridge. This examination is done automatically by the computer program, which evaluates the library prepared in the first general step of the present invention. The atoms checked in this step are the main-chain nitrogen, the alpha carbon, the beta carbon, and the carbonyl carbon of the two amino acids of the selected pair. Within each amino acid, these four atoms form a pyramid with the alpha carbon at the apex and with no easily-changed internal degrees of freedom. The computer program which implements the second general step is broken into two phases. The first phase examines the distance between the centers-of-mass of the pyramids formed within each of the two amino acids of the selected pair. If the distance between the two centers-of-mass is greater than the largest known distance of any of the disulfide linkages in the library, or smaller than the smallest known distance of any of the disulfide linkages in the library, then the selected pair of residues is discarded and the next pair of residues is considered. Alternatively, if the distance between the centers-of-mass of the two residues fall within the range of inter-pyramid distances in the library then the second phase of the second general step is executed for this pair of residues.
In the second phase of the second general step of the present invention, the eigh1_^- atoms forming the pyramids of the two residues in question are considered as a single group having eight three-dimensional coordinates. The structure of> this 8-atom group is compared (according to the method of least squares) to each of the different disulfide bridges contained in the library. The root-mean-squared (RMS) error for the fit of the selected amino acid pair .as compared to each different observed disulfide bond in the library is recorded in computer memory. If for at least one observed disulfide bridge, the RMS error falls below a preset limit then the residue pair in question is recorded as passing the second general step. This preset limit may vary between 0.3 - 0.6 A and is preferably set to a value within the range 0.4 - 0.5 A. When a residue pair passes the second general step an external record is provided which indicates the amino acid pair in question, the identity of the disulfide bond which possess the similar geometry, the RMS error of the analysis and the value of CHI3 of the fit. After this information has been recorded, the computer program searches for a second fit with the restriction that the CHI3 must differ from the CHI3 of the best fit by some preset amount (preferably between 15 - 25 degrees) . If such a second-best fit has a RMS error which is below the threshold written above, then a second record is written indicating the amino acid pair involved, the disulfide bond which provides the second best fit, the RMS error of this second-best fit, and the value of CHI3 of the second-best fit.
If the RMS error does not fall below the preset limit for any of the recorded disulfide linkages, then the current residue pair is rejected and the next pair is examined: For example, with a particular protein of 141 amino acids (such as for example εtaphylococcal nuclease) , 387 amino acid- pairs will pass phase one of the second general step. However, only 27 sites will pass phase two of step two and thus be subject to further consideration. The number of sites to be tested will rise as the square of the number of amino acids which comprise the protein, however, the number of good candidates will rise only linearly with this number. The linear rise in the number of good candidates is a result of the limited number of close neighbors which any residue can have.
3. The Third General Step
In the third general step of the computer based method, the sites listed in the second general step are examined by a computer program to see if the new atoms of the disulfide linkage can be accommodated without altering the tertiary conformation of the protein molecule. Specifically, the new sulfurs of the disulfide bond (to be incorporated into the protein molecule) are positioned according to the observed disulfide which matched best at the site in question in step two. If either or both of the wild-type amino acids are glycines, beta carbons are added as needed. The distance between the sulfurs (and carbons, if new) and all nearby atoms are calculated and a list of distances shorter than physically reasonable (i.e., a list of possible steric contacts) is recorded. This list is divided into two categories based upon the kind of interaction involved: interactions with main-chain atoms and interactions with side-chain atoms (the beta carbon is included as a main chain atom because it cannot be moved by rotation about the side-chain bonds) . To allow for flexibility in the protein and for possible errors in the coordinates recorded in the library, a separation distance at which a contact is taken as unreasonably short is set to some preset amount. This preset amount is smaller than the sum of the van der Waals radii of the atoms in question. This preset value is preferably between 0.4 - 0.6 A, however other values could be used.
Because protein side-chains can rearrange more easily than the main chain, short contacts between atoms of the disulfide bond, and main-chain atoms are considered as potentially more damaging than contacts with side-chain atoms. The sites selected in step two are ordered according to the number of main-chain short contacts. If several sites have identical numbers of main-chain short contacts, these sites are ordered according to the number of side-chain short contacts.
In one embodiment, all sites selected in general step two are passed through to step four with a notation of how many sterically unacceptable contacts exist in each category. An expert user reviews this list and excludes sites with excessive numbers of such contacts.
4. The Fourth General Step
In the fourth general step of the computer based method, an expert operator uses an interactive three- dimensional computer graphics display to view each of the disulfide bond candidates and to rank them from those most likely to stabilize an engineered protein (relative to the wild-type protein) , -to those least likely to stabilize the protein. This ranking is done by considering:
1. the number of short contacts recorded in general step three,
2. whether any of these short contacts can be relieved by slight changes in side-chain or main-chain conformation, or
3. the length of the polypeptide loop created by the disulfide bridge.
5. The Fifth General Step
In the fifth general step of the present invention, sequences of proteins evolutionally related to the wild- type protein are used to discover which amino acids may be most easily altered without seriously reducing the stability of the protein. If many sequences are available for similar proteins from a variety of sources, it may be observed that certain residues are strongly conserved in evolution. This conservation will indicate that, in a given location, one particular amino acid is strongly preferred to give an active, stable protein. At many other locations, however, a plurality of amino acids may be acceptable. This information is used to further rank the candidates to determine which of the possible pairs of residues are most likely to give a stabilizing disulfide bridge. If all other factors are equal, those sites which involve no conserved amino acids are much more likely to give a stabilized disulfide bridge than a site which involves one conserved amino acid, which in turn is much more likely to give a stabilizing disulfide bridge than a site which involves two conserved amino acids.
The elected candidates provide potential sites at which pairs of cysteine residues may be introduced. Mild oxidation of the resulting engineered proteins will give rise to proteins containing disulfide bridges. The method of selecting the sites described in general steps 1-5 makes it highly likely that the resulting engineered proteins will have the same tertiary structure and biological activity as the initial wild-type protein. Moreover, it is highly likely that the engineered proteins will be more stable with regard to agents which cause proteins to unfold (i.e., elevated temperature, altered pH, organic solvents, detergents, or chaotropic salts) .
The parameters of the candidates can be stored for later use. They can also be provided by the user either visually or recorded on a suitable medium (paper, magnetic tape, color slides, CRT, etc) . The results of the various steps utilized in the analysis can be stored for later use or examination. The present invention can be programmed so that certain expert rules are utilized to eliminate unsuitable candidates before they are presented to the operator. These expert rules can be modi ied based on experimental data as more proteins are modified by introduction of disulfide bridges, or as more natural proteins containing disulfide bridges are added to the data base used in general step one.
II. The Invention in Detail
A. The Five General Steps of the Invention
The present invention enables one to identify possible residues which, if replaced by cysteines, might result in the formation of a potentially protein stabilizing disulfide bond. The above-described general steps of the invention may be performed manually, in a semi-automated process or more preferably with the aid of a computer. The best mode for performing the general steps of the invention involves the use of a computer. The computer-assisted method of the best mode is described in related, co-pending, commonly assigned U.S. patent application Serial No. 034,966 , filed concurrently with this application by Pantoliano, M.W. , et al. , which reference has been incorporated by refer¬ ence. B. The Preparation of the Library of Disulfide Linkages
The Brookhaven Protein Data Bank (BPDB) contains structures for between 250 and 300 proteins. Many of these structures contain disulfide bridges. Because this - collection of structures has been obtained from many different laboratories over several years, there is substantial variation in the quality of structures. Most protein structures are refined against diffraction data subject to constraints or restraints. Many proteins do not diffract x-rays very well and consequently insufficient data exists to determine the position of each atom. Furthermore, until quite recently collection of protein diffraction data was very laborious so that crystallographers often did not collect all the data that could be collected.
Crystallographers generally assume that all bond distances and angles are the same as or very close to the distances and angles determined in small-molecule structures where every atom can be localized very accurately. These added data make it possible to construct models of proteins in which each non-hydrogen atom is represented by an x-y-z triplet plus an isotropic temperature factor.
As the methods of the present invention utilize the geometric relationship between two amino acids which might be connected by a disulfide bridge, the most important point to determine about each reported disulfide bridge is whether the report is correct. The eight main-chain atoms have 24 degrees of freedom. Least-squares fitting of a standard pyramid (containing the nitrogen, carbonyl carbon, alpha carbon, and beta carbon of an amino acid) at each end filters out most of the noise in the report coordinates. Finally the six degrees of freedom relating the two standard pyramids are calculated. The November 1986 release of BPDB contained 512 reported disulfide bridges.
Those disulfide linkages which departed from average distances by more than 10% were considered suspicious. The data obtained from these structures may however still be useful, because all that is required is 1) that a disulfide bridge does, in fact, exist, and 2) the nature of the relationship between the two segments of main chain. Thus reported disulfide bridges with incorrect intersulfur distances are not simply rejected, rather attempts to impose correct internal geometry by small movements of the sulfur atoms (i.e., less than 0.2 A) or very small movements- of the beta carbons (less than 0.1A) are made.
Once disulfide bonds with unacceptable and unrepairable geometry are rejected, the program compares each reported disulfide with all others to eliminate geometric duplicates. For this purpose, two disulfide bonds are considered the same if ten of their atoms can be superimposed on the corresponding atoms with an RMS error less than 0.2 A. Removal of duplicates reduced the original 512 reported disulfide bonds to 138 unique ones.
In order to further refine the three-dimensional configuration and intersulfur distances of the disulfide bridges, the pyramid formed from the nitrogen, alpha carbon, beta carbon and carbonyl carbon of the individual cysteines is examined. These 4 atoms have 12 coordinates, yet only 6 degrees of freedom. The pyramids formed from both of the cysteine residues are evaluated as follows. The 8 atoms (of the two pyramids) are translated until one pyramidal cluster set of 4 atoms has its center of mass at the origin. The constellation of 8 atoms is then rotated so that the plane formed by the nitrogen, carbonyl carbon, and the beta carbon is parallel to the X-Y plane. The alpha carbon is then positioned so as to have a positive Z coordinate (the other 3 atoms of the pyramid thus have the same negative Z coordinate) . The pyramid is then rotated about the Z axis until the nitrogen atom has a zero Y coordinate. This defines the standard position for the cysteine residue. The coordinates of this group are shown in Table 1.
Table l Standard N-Ca-Cb-C Pyramid
≥. It z.
N (nitrogen) +1.40047 +0.00000 -0.11897
Ca (alpha C) +0.01174 +0.00259 +0.35693
Cb (beta C) -0.70690 +1.25305 -0.11897
C (carbonyl C) -0.70531 -1.25564 -0.11897
For each different disulfide bond, an external record is written recording:
1) the protein in which the disulfide occurs,
2) the two amino acids involved,
3) the length of the vector from the center of one pyramidal cluster to the other (spherical coordinate, r) ,
4) " the spherical polar angular coordinates phi and theta of the center of the second cluster,
5) the three rotations needed to orient the second cluster about its center,
6) the value of CHI3, the S—S dihedral angle. This list of different observed disulfide bridges is used each time sites for introduction of disulfide bonds are sought for a protein which is to be stabilized. The library need be updated only when one obtains new protein structures containing potentially novel disulfide bridges.
C. The Selection of Sites to Stabilize a Protein.
The process for selecting sites to stabilize a protein is perferably conducted through the use of a computer. The algorithm followed by this program is composed of six different steps. First, in the manner described above, a pyramid whose vertices correspond to the standard coordinates of an amino acid in the protein under study is prepared. This amino acid is designated by the letter "K" and initially (K=l) corresponds to the first amino acid of the protein molecule. A similar standard coordinate pyramid is produced for a second amino acid of the protein under investigation. This second amino acid is designated by the letter "L." Initially, amino acid "L" is one amino acid away from amino acid "K" (i.e., initially, L = K + 1). Once the two coordinate pyramids have been prepared, the distance between them is calculated. The computer program then determines whether the calculated distance between the two pyramids is within the bounds of the disulfide linkages" stored in the library data base. If the calculated distance is not within the bounds of the library, L is tested against N. If L equals N, then K is tested against N-l. If K is less than N-l, then K is set to K+l and L is set to l, and the process iterates. If L was less than N, the L is increased by 1, and the process iterates. If K=N-1 and L=N, then all points have been examined.
If the distance between two calculated pyramids is found to be within the bounds of the values present in the library, then an eight atom image is constructed from the N, C alpha, C beta, and C carbonyl of each of the two pyramids. The computer program then scans the library of known disulfide linkages to find that linkage with the lowest RMS error between the eight atoms of the target protein and the corresponding eight atoms from a library entry. The program then repeats its scan in order to identify a second best fit disulfide linkage, subject to the restriction that CHI3 for the second best fit must differ from CHI3 of the best fit by at least some preset amount, 20° in preferred embodiment. Both the best fit and second best fit are recorded and stored for future use. The computer program then picks a next pair of amino acids by the same method as that used if the distance between pyramids had not been in range.
In the above-described manner the program loops through all possible amino acid K or L. Location of a standard pyramid at amino acids K and L exploits the redundancy of the twelve coordinates which determine the 6 degrees of freedom. If either amino acid K or L is badly distorted, the computer program advises the user of this problem and the faulty amino acid is discarded.
As an example, the protein, staphylococcal nuclease which has 141 amino acids, contains 10,011 amino acid pairs. Of these, 387 were close enough to define a distance which was in the bounds of the disulfide linkages contained in the library.
Significantly, the pair of amino acids being evaluated is tested in both the direction L to K and the direction K to L. This is necessary because the geometries of cystines do not have a two-fold rotational symmetry about the midpoint of the S—S bond.
Once the RMS errors of the amino acid pair is determined relative to each disulfide bridge in the library, the list of RMS errors is scanned to find that entry which produced the smallest error. If this smallest error is below the preset threshold (for example, 0.40 - 0.55 A, preferably 0.45 A), an external record is written. The list of RMS errors is then searched for a second best fit subject to the condition that the dihedral angle CHI3 of the second-best fit must differ from the angle CHI3 by at least some minimal preset amount (i.e., 15 — 25 degrees). This second-best fit is recorded if its RMS error falls below the preset threshold value.
D. The Elimination of Potential Candidates
The above-described computer program provides a list of potential disulfide linkages which may be used to connect two regions of a protein molecule in an effort to stabilize that molecule. If the group of potential linkages is small, it may be feasible for one to construct protein molecules which possess each of the identified disulfide bridges. If, however, the selected group of linkages is large, it may not be possible to produce "an entire set of engineered protein molecules. In such a situation, it is desirable to rank the identified disulfide bridges and to eliminate candidates which are less likely to provide a stabilizing influence on the protein of interest. 1. Elimination of Candidates Based Upon Considerations of Steric Interactions
The stable folding of proteins is dominated by the packing of hydrophobic groups against each other and away from the generally aqueous solvent. It is essential that the volume inside the protein be nearly filled and that polar or charged groups make appropriate interactions with each other or with the solvent molecules. In natural proteins, some water molecules are found inside the protein and form hydrogen bonds with oxygen or nitrogen atoms of the internal surface of the protein. Many carbon and sulfur atoms (and the hydrogen atoms covalently bound to these atoms) are found to be in van der Waals contact with other non- polar atoms. Proteins form such densely packed structures . because a tightly compressed protein structure allows greater volume to the water and thus increases the entropy of the solvent. Hence, protein structure is not predominantly the result of the very weak attractive van der Waals forces between the protein atoms. In natural proteins, atoms are never closer than their van der Waals radii contact because of repulsive forces.
The simplest selection process for potential disulfide bridges would be to place all the atoms in the candidate structures and to then calculate the interatomic separations between the atoms of the disulfide bridge and all the retained atoms of the native protein. Candidates in which two atoms appear to be closer than permitted would be rejected. This very simple method is not used for two reasons: (1) The recorded protein coordinates may contain errors.
(2) Protein structures are not static, and hence some steric hindrance may be permissible.
Thus, in order to eliminate less probable candidates on the basis of packing considerations, a more sophisticated analysis is required. A potential steric interference between the atoms is recorded only when the atoms are closer than their van der Waals radii by some preset amount (i.e., preferably 0.4 - 0.6 A). Moreover, such contacts are divided into two classes which are separately evaluated. The first considered class are those in which the potentially interfering atoms are members of the main-chain of the protein. Contacts with main-chain atoms are more serious because the motion needed to relieve any steric interference might seriously disrupt the tertiary structure of the protein. In contrast, conflicts between hypothetical disulfide bridge atoms and atoms in other side chains might be easily relieved through rotations about side- chain bonds. Because of these considerations, the beta carbon is considered a main-chain atom because it is not moved by rotations about any side-chain bond.
Given the number of sites at which main-chain groups are correctly related for introduction of a new disulfide bridge, it is usually possible to find several of these sites for which there are no short contacts (i.e., steric interference) with either main-chain atoms or side-chain atoms.
A second consideration in evaluating possible disulfide bridges is to not lose favorable hydrophobic interactions. Thus, conversion of tryptophan, tyrosine, and phenylalanine residues to cysteine is probably
A21.3.WP 032387 unfavorable because this would create a large hole inside the protein. In contrast, conversion of leucine, isoleucine, or methionine into cysteine is only mildly unfavorable.
2. Elimination of Candidates Based Upon Considerations of Sequence Conservation
A tenet of evolution is that the replication of genes is not error-free. Each error in copying a gene potentially alters the meaning of the encoded message. Because the genetic code has redundancies, many copying errors are silent and do not result in a change in the amino acid sequence encoded by the gene. For example, a mutation which changes a codon sequence of AAG into the codon sequence AAA would not effect the amino acid sequence of the encoded protein (which would in both cases be the amino acid lysine) .
If a particular protein is produced in several different species, then, by comparing their amino acid sequences, it is possible to obtain insight into which amino acid residues appear to have been conserved (and thus probably essential) throughout evolutionary time. In evaluating potential positions for disulfide bridges, it is, therefore, desirable not to remove or alter any evolutionally conserved amino acid sequences. Thus, the number of potential candidate linkages may be reduced through a consideration of evolutionary protein change. E. Recombinant DNA Manipulations
1. Production of Engineered Proteins
The primary amino acid sequence of a protein may be stored within the deoxyribonucleic acid (DNA) of a cell capable of producing that protein. Thus, by altering the DNA which encodes a particular protein, it is possible to change that protein's primary sequence. Although it is possible to change a protein's amino acid sequence either directly (as by incorporating additional cysteine residues by synthetic or semi-synthetic methods) or indirectly (as by altering the DNA or RNA sequence which encodes that protein, it is far more advantageous to alter the protein's amino acid sequence indirectly. Indirect means are preferred because (1) it is far easier to alter a DNA sequence than to alter a protein sequence, and (2) the capacity of DNA to self- replicate enables one to produce ah inexhaustible supply of the desired protein molecule.
The process through which DNA is decoded to produce a protein molecule involves the synthesis of a ribonucleic acid (RNA) intermediary. The process through which RNA is produced is known as "transcription." The process through which the RNA molecule is decoded to produce a protein molecule is referred to as "translation." A description of these processes can be found in The Structure and Action of Proteins (Dickerson, R.E. et al. , W.A. Benjamin, Inc., CA. (1969)) and Molecular Biology of the Gene (Watson, J.D.; W.A. Benjamin, Inc., New York (1970)). The overall processes through which a DNA sequence is converted into a protein is often referred to as "gene expression." The expression of a DNA sequence requires that the sequence be "operably linked" to DNA sequences which contain transcriptional and translational regulatory information. An operable linkage is a linkage in which the regulatory DNA sequences and the sequences sought to be expressed are connected in such a way as to permit gene expression. The regulatory DNA sequences involved in gene expression are termed "promoters."
The term "promoter" as used herein refers to a region of regulatory DNA sequence which is recognized by a cell as a site adjacent to which to begin the initiation of the transcription of DNA into RNA. Examples of promoters from prokaryotic cells or from viruses' which infect prokaryotic cells, include the E. coli recA, lac, and trp promoters (Shirakawa, M. et al. , Gene, 2.8:127-132 (1984)) or the left promoter of bacteriophage lambda (P_.) (Devare, S . G . , et al. Cell, 16_:43-49 (1984)). Examples of promoters from eukary- otic cells or from viruses which infect such cells include the promoter of the mouse metallothionein I gene (Ha er, D. , et al. , J. Mol. Appl. Gen. 1:273-288 (1982)); the TK Promoter of Herpes, virus (McKnight, S., Cell 31:355-365 (1982)); and the SV40 early promoter (Benoist, C. et al.. Nature, 290:304-310 (1981)).
Thus, in order to produce a protein, a genetic sequence which encodes that protein is operably linked to a promoter region, and introduced into a suitable cell (such as E. coli, Bacilles, yeast, or mammalian cells) . A DNA sequence may be introduced into a cell by any of several means: transduction, transformation, conjugation, or microinjection, although it is most preferable to use transformation (Botstein, D. , et al. , The Molecular Biology of the Yeast Saccharomyces: Metabolism and Gene Expression, Cold Spring Harbor, N. Y., HB:607-636 (1982); Struhl, K. , Nature, 305:391-397 (1983); Bollon, A. P., et al. , J. Clin. Hematol. Oncol. 10:39-48 (1980); Wigler, M. et al. , Proc. Natl. Acad. Sci. (U.S.A.), 76:1373-1376 (1979); Davis, R. W. , et al. , A Manual for Genetic Engineering Advanced Bacterial Genetics, Cold Spring Harbor, N.Y. (1980); Maniatis, T. , et al.f Molecular Cloning A Laboratory Manual, Cold Spring Harbor, N. Y. (1982) ; Miller, J. H. , Experiments in Molecular Genetics, Cold Spring Harbor, N. Y. (1972) ) .
The genetic sequences which are capable of expressing the engineered proteins of the present invention are advantageously incorporated into self- replicating DNA plasmids. A plasmid is a covalently closed circular extrachromosomal nucleic acid molecule. In general, a plasmid contains two elements: (1) An origin of replication sufficient to permit the propagation of the plasmid in a host cell; and (2) a selectable marker sequence, preferably a gene whose expression confers an antibiotic resistance to the host cell, sufficient to enable the maintenance of the plasmid within the host cell and to facilitate the manipulation and introduction of the plasmid into new host cells.
In summary, it is preferable to produce the engineered proteins of the present invention by manipulating the DNA sequences which encode those proteins. The manipulated DNA is then preferably incorporated into a plasmid molecule and introduced into a host cell which is capable of expressing such sequences, thereby producing the engineered protein molecule.
2. Production of Engineered Proteins by in vitro Mutagenesis of DNA
Techniques of in vitro mutagenesis involving M13 or its derivatives are disclosed by Kunkel, fProc. Natl. Acad. Sci. U.S.A.. 82:488-492 (1985)), Nisbet, I.T., et al. (Gene Anal. Tech., 2:23-29 (1985)) , and Hines, J.C., et al. r (Gene , .11.: 207-218 (1980)) , which are incorporated herein by reference. In brief, the procedure entails the synthesis of a synthetic oligonucleotide having a desired and defined DNA sequence. M13, or one of its derivatives, is converted to its single strand form, and incubated in the presence of the synthetic oligonucleotide. Since the DNA of the oligonucleotide is controllably defined, it is possible to construct an oligonucleotide capable of pairing with a complementary DNA sequence present on the single stranded plasmid. Once base pairing has occurred between the oligonucleotide and the single stranded plasmid, it is possible to extend the oligonucleotide using DNA polymerase to create a double stranded DNA molecule which may then be sealed by DNA ligase. When this double stranded DNA molecule is introduced into a bacterial cell, semi-conservative DNA replication will result in the production of progeny molecules which now contain the DNA sequence of the oligonucleotide fragment (Messing, J., et al . , Nucl. Acid Res. , 9_:309 (1981) .
Thus, if one desires to introduce a cysteine residue into a specific site of a protein molecule one would design an oligonucleotide fragment which contains the codon for cysteine and then pursue the above described procedure. In order to introduce this mutation or exogenous DNA sequence into a particular region of a plasmid, it is necessary to surround the mutation or the exogenous DNA sequence with flanking DNA sequences which are complementary to the DNA sequence of the region whose mutagenesis is desired.
As an example, if a wild-type protein contains the amino acid sequence lysine-serine-leucine, then the corresponding DNA sequence might be AAA-TCT-CTT. If one desires to replace the serine with a cysteine residue, one would produce a DNA sequence such as AAA-TGT-CTT. The use of this oligonucleotide in the above-described in vitro mutagenesis method would result in the production of an altered gene which expresses a protein containing a cysteine residue in place of the original serine residue. In a similar manner, a cysteine residue can be incorporated into any position of any protein molecule.
Having now generally described this invention, the same will be better understood by reference to certain specific examples which are included herein for purposes of illustration only and are not intended to be limiting of the invention, unless specified.
EXAMPLE I
Production of Stabilized Serine Proteases
Serine proteases are proteolytic enzymes which have a serine residue at their active site. Many species of bacteria are known to secrete such serine proteases into the culture medium. Serine proteases can be inhibited by ph e n y 1 m e th a n e s u 1 f o ny 1 f 1 o r i de and/or disopropylfluorophosphate. Subtilisin is a serine protease produced by Gram positive bacteria and fungi. The amino acid sequences of seven different subtilisins are known. These include five subtilisins (SBT) from Gram positive bacteria of the genus, Bacillus. The subtilisin produced by Bacillus amylolicruifaciens (hereinafter referred to as SBT BPN') was selected as a model protein and used to prepare an engineered, more stable protein. The wild type SBT BPN' enzyme is discussed by Vasantha, et al. (J. Bacteriol. , 159: 811- 819 (1984) . The three-dimensional structure of SBT BPN' has been determined to a resolution of 1.3 A.
The number of potential pairs of disulfide linkage sites in a protein such as SBT BPN' is obtained from the following equation:
Number of = N (N - 1) possible 2 pairs
Hence, for a protein such as subtilisin, which has 275 amino acid residues (i.e., N = 275) 37,675 different pair wise combinations are possible. Without the above- described computer method, it would be necessary to evaluate all of these possibilities experimentally.
Therefore, the above-described method for identifying potential sites which could be -linked together with disulfide bonds was used in order to predict those linkages which would result in a more stable subtilisin protein. Before the computer method was applied, sites which included any of the residues Ser 221, Ser 125, His 64 or Asp 32 were discarded,
A21.3.WP 032387 since these residues are essential for subtilisin's catalytic activity. The results of the computer search for potential disulfide bond positions is shown in Table
Table 2 Sites Selected for New Disulfide Bridges Using Geometry and Packing Based on the 1.3 A Crystal Structure of SBT BPN'
Residues Strain RMSa Short Short linked GX error M/C S/C CHI
G 7:P201 0.26 1 2 259
Y 21 :S236 0.45 0 0 274
T 22 :S 87 7159 0.39 0 0 244
G 23 :A 88 0.44 4 0 " 270
V 26 :A232 0.45 0 1 259
V 26 :L235 7157 0.42 0 0 275
A 29 :A114 0.36 0 2 273
A 29 :M119 0.44 0 0 149
I 31 :G110 0.17 1 2 268
I 35 :A 69 0.28 3 0 84
I 35 :A 69 0.38 6 0 269
D 36 :H 39 0.18 - - 244
D 41 :G 80 0.22 - - 84
D 41 :G 80 0.26 - - 269
G 47 :P 57 0.36 3 3 89
M 50 :N109 7168 0.30 0 0 275
P 57 :K 94 0.35 - - 71
A 85 :A 88 0.40 - - 244
V 93 .GllO 0.38 * - - 268
V 95 :I107 0.43 - - 101
V 95 GllO 0.42 - - 88
N123 .A228 0.29 - - 78
V150 A228 0.36 - - 93
V150 A228 0.45 - - 226
A153 V165 0.38 1 0 252
E156 T164 0.29 0 1 89
S163 G193 0.44 - - 65
V165: K170 0.41 0 2 145
V165: Ξ191 0.23 3 0 101
Y167: K170 0.44 - - 108
V177: S224 0.44 - - 226
A179: A223 0.31 - - 45
A200: H226 0.44 - - 269
Q206: A216 8307 0.27 0 0 - 88
A230: V270 0.35 0 1 90
1234: A274 0.41 0 0 274
H238: W241 0.36 0 0 244
T253: A272 0.42 - - 89
T253: A273 7140 0.29 - - 93
T253: A273 II 0.29 t 226
aOnly RMS values of 0.45 and below were used selecting these candidates. In Table 2, the residues linked together are denoted using the single letter code for amino acids (see Table 3) and by the amino acid position number. Hence, the first linkage shown (G7:P201) denotes a potential linkage between cysteines which would replace the glycine which appears at position 7 of subtilisin and the proline which appears at position_ 201. The second column of Table 2 indicates whether a bacterial strain was constructed which expressed a protein having the indicated disulfide linkage. The third column is the RMS error for the best fit of the geometry of the candidate amino acid pair with that of any observed disulfide bond in the Brookhaven Protein Data Bank. The next two columns list the short contacts that occur between main or side-chain atoms (Short M/C; Short S/C) and thus provide an indication of the number of potential points of steric hindrance which are predicted to be present in the engineered protein. The final column of Table 2 provides the CHI3 angle of the bond in degrees.
Table 3 Letter Codes for the Naturally Occurring Amino Acids
Alanine ALA A
Arginine ARG R
Aspartic acid ASP D
Asparagine ASN N
Cysteine CYS C
Glutamic acid GLU E
Glutamine GLN Q
Glycine GLY G
Histidine HIS H
Isoleucine TLE I
Lysine LYS K
Leucine LEU L
Methionine MET M
Phenylalanine PHE F
Proline PRO P
Serine SER S
Threonine THR T
Tryptophan TRP w
Tyrosine TYR Y
Valine VAL V
EXAMPLE II
Elimination of Selected Candidates on the Basis of Packing and Sequence Conservation
Since the subtilisins from several Bacillus strains have been purified and sequenced, it is possible to compare these sequences and thereby identify conserved amino acid residues. In performing this comparison, the following references were employed: SBT BPN1 (Vasantha et al . , J . Bacteriol .
159.: 811-819 (1984) ) ; SBT Carlsberg (Jacobs et al. ,
Nucleic Acid Res. 13.: 8913-8926 (1985)) ; SBT DY (Nedov et al . , Biol . Chem. 366:421-430 (1985) ) ; SBT amylosaccha iticus (Kurihara et al. , J^. Biol. Chem. 247:5619-5631 (1972)) ; and Mesenticopeptidase (Svendsen et al■ . FEBS Lett. 196:228-232 (1986)) .
The amino acid sequence of the subtilisin thermitase from Thermoactmomyces vulgaris is also known (Meloun et al■ , FEBS Lett. 183:195-200 (1985)). The amino acid sequences from two fungal serine proteases are also partially known: proteinase K (Jany et al. , Biol. Chem. Hoppe-Seyler 366: 485-492 (1985)) and thermomycolase (Gaucher et al . , Methods Enzymol. 5.:415-433 (1976)).
These enzymes have been shown to be related to subtilisin BPN' , not only through thei-r primary sequence and enzymological properties, but also by comparison of x-ray crystallographic data (McPhalen et al. , FEBS Lett. 188:55-58 (1985) and Pahler et al.. EMBO J. 2:1311-1314 (1984) ) . A comparison of subtilisin amino acid sequences is shown in Table 4. Table 4 Subtilisin Sequences
Key: 1 Subtilisin BPN'
2 Subtilisin Amylosacchariticus
3 Mesenticopeptidase
4 Subtilisin Carlsberg
5 Subtilisin DY
6 Thermitase
Sequences 1-5 are from bacilli.
XXX Conserved in all sequences - (capitalized and underlined)
XXX Conserved in 111Bacillus - (capitalized) xxx Varies within 111 toBacillus - (lower case) 111
PROTEASE
RESIDUE 1 3 4 5 6 -7 TYR -6 THR -5 PRO -4 ASN -3 ASP -2 PRO -1 TYR 1 ALA ALA ALA ALA ALA PHE
2 GLN GLN GLN GLN GLN SER
3 ser ser ser thr thr ser
4 VAL VAL VAL VAL VAL ARG
5 PRO PRO PRO PRO PRO GLN
6 TYR TYR TYR TYR TYR TRP
7 GLY GLY GLY GLY GLY GLY
8 val ile ile ile ile pro
9 ser ser ser pro pro gin
10 gin gin gin leu leu lys
11 ILE ILE ILE ILE ILE ILE
12 LYS LYS LYS LYS LYS GLN
13 ALA ALA ALA ALA ALA ALA
14 pro pro pro asp asp pro
15 ala ala ala lys lys gin
16 - leu leu leu val val ala
17 his his his gin gin trp
18 ser ser ser ala ala asp
19 GLN GLN GLN GLN GLN ILE
20 GLY GLY GLY GLY GLY ALA
21 tyr tyr tyr phe tyr glu
22 thr thr thr lys lys
23 GLY GLY GLY GLY GLY GLY
24 ser ser ser ala ala ser 25 ASN ASN ASN ASN ASN GLY
26 VAL VAL VAL VAL VAL ALA
27 LYS LYS LYS LYS LYS LYS
28 VAL VAL VAL VAL VAL ILE
29 ala ala ala ala gly ala
30 val val val val ile ile
31 ile ile ile leu ile val
32 ASP ASP ASP ASP ASP SP
33 ser ser ser thr thr thr
34 GLY GLY GLY GLY GLY GLY
35 ILE ILE ILE ILE ILE VAL
36 asp asp asp gin ala gin
37 ser ser ser ala ala ser
38 SER SER SER SER SER ASN
39 HIS HIS HIS HIS HIS HIS
40 pro pro pro pro thr pro
41 ASP ASP ASP ASP ASP ASP
42 LEU LEU LEU LEU LEU LEU
43 lys asn asn asn lys ala
44 VAL VAL VAL VAL VAL GLY
45 ala arg arg val val lys
46 GLY GLY GLY GLY GLY VAL
47 GLY GLY GLY GLY GLY VAL
48 ALA ALA ALA ALA ALA GLY
49 SER SER SER SER SER GLY
50 met phe phe phe phe trp
51 VAL VAL VAL VAL VAL ASP
52 pro pro pro ala ser phe
53 ser ser ser gly gly val
54 GLU GLU GLU GLU GLU GLU
55 thr thr thr ala ser gin
56 asn asn asn asp
57 pro pro pro tyr tyr ser
58 phe tyr tyr asn asn thr
59 gin gin gin thr thr pro
60 ASP ASP ASP ASP ASP GLN
61 asn gly gly gly gly gly
62 asn ser ser asn asn asn
63 ser ser ser gly gly gly
64 HIS HIS HIS HIS HIS HIS
65 - GLY GLY GLY GLY GLY GLY
66 THR THR THR THR THR THR
67 HIS HIS HIS HIS HIS HIS
68 VAL VAL VAL VAL VAL CYS
69 ALA ALA ALA ALA ALA ALA
70 GLY GLY GLY GLY GLY GLY
71 THR THR THR THR THR ILE
72 val ile ile val val ala
73 ALA ALA ALA ALA ALA ALA 74 ALA ALA ALA ALA ALA ALA
75 LEU LEU LEU LEU LEU VAL
75a THR
76 asn asn asn asp asp asn
77 ASN ASN ASN ASN ASN ASN
78 ser ser ser thr thr ser
79 ile ile ile thr thr thr
80 GLY GLY GLY GLY GLY GLY
81 VAL VAL VAL VAL VAL ILE
82 LEU LEU LEU LEU LEU ALA
83 GLY GLY GLY GLY GLY GLY
84 VAL VAL VAL VAL VAL THR
85 ALA ALA ALA ALA ALA ALA
86 PRO PRO PRO PRO PRO PRO
87 ser ser ser ser asn lys
88 ala ala ser val val ala
89 ser ser ala ser ser ser
90 LEU LEU LEU LEU LEU ILE
91 TYR TYR TYR TYR TYR LEU
92 ALA ALA ALA ALA ALA ALA
93 val val val val ile val
94 ' LYS LYS LYS LYS LYS ARG
95 VAL VAL VAL VAL VAL VAL
96 LEU LEU LEU LEU LEU LEU
97 gly asp asp asn asn asp
98 ala ser ser ser ser asn
99 asp thr thr ser ser ser
100 GLY GLY GLY GLY GLY GLY
101 SER SER SER SER SER SER
102 GLY GLY GLY GLY GLY GLY
103 gin gin gin thr thr thr
104 TYR TYR TYR TYR TYR TRP
105 SER SER SER SER SER THR
106 trp trp trp gly ala ala
107 ILE ILE ILE ILE ILE VAL
108 ile ile ile val val ala
' 109 asn asn asn ser ser asn
110 GLY GLY GLY GLY GLY GLY
111 ILE ILE ILE ILE ILE ILE
112 GLU GLU GLU GLU GLU THR
113 TRP TRP TRP TRP TRP TYR
114 ALA ALA ALA ALA ALA ALA
115 ile ile ile thr thr ala
116 ala ser ser thr gin asp
117 ASN ASN ASN ASN ASN GLN
118 asn asn asn gly gly gly
119 met met met met leu ala
120 ASP ASP ASP ASP ASP LYS
121 VAL VAL VAL VAL VAL VAL 122 ILE ILE ILE ILE ILE ILE
123 ASN ASN ASN ASN ASN SER
124 MET MET MET MET MET LEU
125 SER SER SER SER SER SER
126 LEU LEU LEU LEU LEU LEU
127 GLY GLY GLY GLY GLY GLY
128 GLY GLY GLY GLY GLY GLY
129 PRO PRO PRO PRO PRO THR
130 ser ser thr ser ser val
131 GLY GLY GLY GLY GLY GLY
132 SER SER SER SER SER ASN
133 ala thr thr thr thr ser
134 ALA ALA ALA ALA ALA GLY
135 leu leu leu met leu leu
136 LYS LYS LYS LYS LYS GLN
137 ala thr thr gin gin gin
138 ala val val ala ala ala
139 VAL VAL VAL VAL VAL VAL
140 ASP ASP ASP ASP ASP ASN
141 lys lys lys asn lys tyr
142 ALA ALA ALA ALA ALA ALA
143 val val val tyr tyr trp
144 ala ser ser ala ala asn
145 ser ser ser arg ser lys
146 GLY GLY GLY GLY GLY GLY
147 val ile -ile val ile ser
148 VAL VAL VAL VAL VAL VAL
149 VAL VAL VAL VAL VAL VAL
150 val ala ala val val val
151 ALA ALA ALA ALA ALA ALA
152 ALA ALA ALA ALA ALA ALA
153 ALA ALA ALA ALA ALA ALA
154 GLY GLY GLY GLY GLY GLY
155 ASN ASN ASN ASN ASN ASN
156 glu glu glu ser ser ala
157 GLY GLY GLY GLY GLY GLY
158 thr ser ser ser ser asn
159 SER SER SER SER SER THR
160 GLY GLY GLY GLY GLY ALA
161 ser ser ser asn ser pro
162 - ser ser thr thr gin asn
163 ser ser ser asn asn
164 THR THR THR THR' THR
165 val val val ile ile
166 GLY GLY GLY GLY GLY
167 TYR TYR TYR TYR TYR TYR
168 PRO PRO PRO PRO PRO PRO
169 gly ala ala ala ala ala
170 LYS LYS LYS LYS LYS TYR 171 TYR TYR TYR TYR TYR TYR
172 pro pro pro asp asp ser
173 SER SER SER SER SER ASN
174 val thr thr val val ala
175 ILE ILE ILE ILE ILE ILE
176 ALA ALA ALA ALA ALA ALA
177 VAL VAL VAL VAL VAL VAL
178 GLY GLY GLY GLY GLY ALA
179 ALA ALA ALA ALA ALA SER
180 VAL VAL VAL VAL VAL THR
181 asp asn asn asp asp asp
182 SER SER SER SER SER GLN
183 ser ser ala asn asn asn
184 asn asn asn ser lys asp
185 gin gin gin asn asn asn
186 ARG ARG ARG ARG ARG LYS
187 ALA ALA ALA ALA ALA SER
188 SER SER SER SER SER SER
189 PHE- PHE PHE PHE PHE PHE
190 SER SER SER SER SER SER
191 SER SER SER SER SER THR
192 val ala ala val val tyr
193 GLY GLY GLY GLY GLY GLY
194 pro ser ser ala ala ser
195 GLU GLU GLU GLU GLU VAL
196 LEU LEU LEU LEU LEU VAL
197 asp asp asp glu glu asp
198 VAL VAL VAL VAL VAL VAL
199 MET MET MET MET MET ALA
200 ALA ALA ALA ALA ALA ALA
201 PRO PRO PRO PRO PRO PRO
202 GLY GLY GLY GLY GLY GLY
203 val val val ala val ser
204 ser ser ser gly ser trp
205 ile ile ile val val ile
206 gin gin gin tyr tyr tyr
207 SER SER SER SER SER SER
208 THR THR THR THR THR THR
209 leu leu leu tyr tyr tyr
210 PRO PRO PRO PRO PRO PRO
211 gly gly gly thr ser thr
212 asn gly gly ser asn ser
213 lys thr thr thr thr thr
214 TYR TYR TYR TYR TYR TYR
215 gly giy gly ala thr ala
216 ala ala ala thr ser ser
217 tyr tyr tyr leu leu leu
218 ASN ASN ASN ASN ASN SER
219 GLY GLY GLY GLY GLY GLY 220 THR THR THR THR THR THR
221 SER SER SER SER SER SER
222 MET MET MET MET MET MET
223 ALA ALA ALA ALA ALA ALA
224 ser thr thr ser ser thr
225 PRO PRO PRO PRO PRO PRO
226 HIS HIS HIS HIS HIS HIS
227 VAL VAL VAL VAL VAL VAL
228 ALA ALA ALA ALA ALA ALA
229 GLY GLY GLY GLY GLY GLY
230 ALA ALA ALA ALA ALA VAL
231 ALA ALA ALA ALA ALA ALA
232 ALA ALA ALA ALA ALA GLY
233 LEU LEU LEU LEU LEU LEU
234 ILE ILE ILE ILE ILE LEU
235 LEU LEU LEU LEU LEU ALA
236 SER SER SER SER SER SER
237 LYS LYS LYS LYS LYS GLN
238 his his his his tyr
239 PRO PRO PRO PRO PRO
240 asn thr thr asn thr gly
241 trp trp trp leu leu arg
242 thr thr thr ser ser ser
243 asn asn asn ala ala ala
244 thr ala ala ser ser ser
245 GLN GLN GLN GLN GLN ASN
246 VAL VAL VAL VAL VAL ILE
247 ARG. ARG ARG ARG ARG ARG
248 ser asp asp asn asn ala
249 ser arg arg arg arg ala
250 LEU LEU LEU LEU LEU ILE
251 glu glu glu ser ser glu
252 asn ser ser ser ser asn
253 THR THR THR THR THR THR
254 thr ala ala ala ala ala
255 THR THR THR THR THR ASP
256 lys tyr tyr tyr asn lys
257 LEU LEU LEU LEU LEU ILE
257a SER
258 GLY GLY GLY GLY GLY GLY
259 asp asp ser ser asp thr
260 SER SER SER SER SER GLY
261 PHE PHE PHE PHE PHE THR
262 TYR TYR TYR TYR TYR TYR
263 TYR TYR TYR TYR TYR TRP
264 GLY GLY GLY GLY GLY ALA
265 LYS LYS LYS LYS LYS LYS
266 GLY GLY GLY GLY GLY GLY
267 LEU LEU LEU LEU LEU ARG 268 ILE ILE ILE ILE ILE VAL
269 ASN ASN ASN ASN ASN ASN
270 VAL VAL VAL VAL VAL ALA
271 gin gin gin glu glu tyr
272 ALA ALA ALA ALA ALA LYS
273 ALA ALA ALA ALA ALA ALA
274 ALA ALA ALA ALA ALA VAL
275 GLN GLN GLN GLN GLN GLN
276 TYR
Comparing all sequences, there are 91 completely conserved residues while 194 of the residues vary. The
Bacillus sequences are more closely related with 171 of
275 being conserved. The 40 potential disulfide linkage sites identified by the computer program were then analyzed to determine whether any of these linkages would involve the alteration of a conserved amino acid residue. Those residue linkages which did not result in the alteration of a conserved amino acid are shown in
Table 5.
Table 5 Sites Selected for New Disulfide Bridges Using Geometry, Packing, & Homology
Residues Strain RMSβ Short Short linked GX error M/C S/C CHI
T 22:S 87 7159 0.39 0 0 244
V 26:L235 7157 0.42 0 0 275
G 47 :P 57 0.36 3 3 89
M 50:N109 7168 0.30 0 0 275
E156:T164 0.29 0 1 89
V165:K170 0.41 0 2 145
V165:Ξ191 0.23 3 0 - 101
Q206:A216 8307 0.27 0 0 88
A230:V270 0.35 0 1 90
I234:A274 0.41 0 0 274
H238:W241 0.36 0 0 244
^Only RMS values of 0.45 A and below were use selecting these candidates. As seen in Table 5, 11 linkages were identified as possible candidates for introduced disulfide bonds that would increase the stability of SBT BPN'. The 11 linkages were then examined to identify those linkages having the least RMS error and the fewest steric hindrances (short contact main-chain and side-chain interactions) . Six out of these eleven are shown to have no short contacts with main-chain and side-chain atoms. Four of these, T22:S87, Y26:L235, M50:N109, and Q206:A216 were selected for oligonucleotide-directed mutagenesis, and the variant proteins containing these selected disulfide bridges were called subtilisin 7159, 7157, 7168, and 8307, respectively.
EXAMPLE III
Production of Engineered Proteins
' Using the technique of oligonucleotide-directed in vitro mutagenesis, described above, strain GX7157 was constructed. In this strain, the SBT BPN' protein contains cysteine residues at position 26 (replacing valine) and at position 235 (replacing leucine) . Strain GX7157 was found to be capable of producing and secreting subtilisin. The disulfide bond may have formed, but the resultant protein was decidedly less stable than wild-type. It was observed that the" single substitution of a cysteine for the lysine residue at position 235 was mildly destabilizing. In contrast, the engineered protein which possessed a cysteine instead of a valine at position 26 was approximately as stable as the wild-type protein. A second mutant strain was constructed which contained cysteines at position 50 (replacing methionine) and position 109 (replacing asparagine) . This mutant strain was designated GX7168. Subtilisin was produced in this strain and secreted, however, the engineering protein was decidedly less stable than wild- type.
A third mutant strain was constructed in which the threonine at position 22 and the serine at position 87 were replaced by cysteines. This mutant was designated GX7159. The subtilisin secreted by this strain was found to contain the desired disulfide bond. This engineered protein was decidedly more stable than wild- type subtilisin.
In 10 mM calcium chloride, the rate for thermal inactivation of subtilisin 7159 (i.e., produced from mutant strain GX7159) is 1.1 times slower than wild-type subtilisin BPN1 at 65°C. In 1 mM EDTA, the rate of thermal inactivation at 45"C for subtilisin 7159 is 1.5 to 2.0 times slower than that for wild-type subtilisin BPN'. It is well known that subtilisin is stabilized by free calcium ions. Many preparations for washing clothes contain agents to sequester calcium because free calcium interferes with the action of detergents. Thus the improved stability of subtilisin 7159 in a calcium-free environment (i.e. , an environment containing EDTA) is especially useful.
In addition, subtilisin 7159 was melted in a differential scanning calorimeter. In 10 mM calcium chloride, subtilisin 7159 melted 0.5°C above the melting temperature of wild-type subtilisin. In 10 mM EDTA, subtilisin 7159 melted 3.1°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 7159 was substantially more thermodynamically stable than the wild-type protein.
A mutant was constructed which contained cysteine residues at position 206 (replacing glutamine) and at position 216 (replacing alanine) . This mutant was designated GX8307. The subtilisin secreted by this mutant was found to contain the desired disulfide bond. The subtilisin produced by GX8307 (termed subtilisin 8307) was decidedly more stable than wild-type subtilisin.
In 10 mM calcium chloride, the rate for thermal in¬ activation at 65°C for subtilisin 8307 is 1.1 times slower than that of wild-type subtilisin BPN' . In 1 mM EDTA, the rate of thermal inactivation at 45°C for subtilisin 8307 is also 1.5 to 2.0 times slower than wild-type subtilisin BPN' . In addition, subtilisin 8307 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 8307 melted about 3.0°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 8307 was substantially more stable than the wild-type protein. Since, as indicated above, subtilisin is stabilized by free calcium ions, the improved stability of subtilisin 8307 in a calcium-free environment is again especially useful for an enzyme to be introduced into detergents for washing clothes.
Using oligonucleotide-directed mutagenesis, the disulfide bond of subtilisin 7159 (cysteines at positions 22 and 87) was combined in the same subtilisin molecule with a stabilizing mutation (asparagine 218 to serine) identified by random mutagenesis. (The 218 random mutation is described in co-pending, commonly assigned PCT Patent Application 87/00348.) This new subtilisin molecule (subtilisin 7181) , which was secreted by strain GX7181, contained the desired disulfide bond and was decidedly more stable than wild- type.
Subtilisin 7181 was crystallized isomorphously to wild-type subtilisin. Using these crystals, x-ray data was collected to a resolution of 1.8 A. The phases of wild-type subtilisin were used to initiate Hendrickson- Konnert refinement (Hendrickson, W.H. and Konnert, J.H. (1980) In: Computing in Crystallography, (Diamond, R. , Ranseshan, S. and Venkatesan, K. , eds.), pp. 13.01- 13.23, Indian Institute of Science, Bangalore) which was continued until the crystallographic R index was 14.5. The disulfide bridge was found to be in the predicted conformation.
In 10 M calcium chloride, the rate of thermal inactivation of subtilisin 7181 is 4.0 times slower than that of wild-type subtilisin BPN' at 65°C. In 1 mM EDTA, the rate of thermal inactivation at 45°C for subtilisin produced by GX7181 is approximately 5.2 times slower than that of wild-type subtilisin BPN1. In addition, subtilisin 7181 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 7181 melted 7.5°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 7181 was substantially more stable than the wild-type protein. Thus, the subtilisin produced by GX7181, which exhibits improved stability in a calcium-free environment, is especially useful in preparations which contain detergents.
Also using oligonucleotide-directed mutagenesis, the disulfide bond of subtilisin 7159 (cysteines at positions 22 and 87) was combined with the disulfide bond of subtilisin 8307 (cysteines at positions 206 and 216) to create subtilisin 8310. Subtilisin 8310, produced by strain GX8310, was found to be secreted and to contain both of the desired disulfide bonds. Subtilisin 8310 was melted in a differential scanning calorimeter. In 10 mM EDTA, subtilisin 8310 melted about 5.5°C above the melting temperature of wild-type subtilisin. Thus, subtilisin 8310 was substantially more stable than the wild-type protein.
The reasons for the failure of the disulfide linkages contained in subtilisin 7157 and 7168 to stabilize these proteins is unknown at the present time. Residues Val 26 and Leu 235 which are changed to cysteines in subtilisin 7157 are less variable than many of the other residues listed in Table 5, especially when compared with those involved in the disulfide linkages of 22/87 and 206/216. Residues 26 and 235 are absolutely conserved within the Bacillus genus, and differ only in the thermitase sequence from Thermoactmomyces. These residues are decidedly more hydrophobic than those comprising the disulfide linkages in subtilisin 7159 and 8307. It is believed that one loses more stability from removing hydrophobic residues from the interior of the protein than one can gain from the effect of a crosslink on the entropy of the unfolded state. The 50/109 linkage may also suffer from this same problem since only very hydrophobic groups (Met, Phe, and Trp) are found at this position.
Additional considerations such as these could lead to an improvement in the probability for selecting stabilizing disulfide linkages. Nonetheless, even without any further modifications of this method, its -success rate for predicting candidate sites on proteins for the introduction of disulfide linkages is two out of four or 50%. No other known method for selecting disulfide linkages approaches this level of success. The method of Wetzel (European Patent Appln. 155,832) has no success in selecting sites when more than one cysteine needs to be changed.
As an indication of the necessity for the various steps and rules defined in this present invention, and also as an insight to how they evolved and were formulated, it becomes instructive to review examples of engineered disulfide linkages that failed to stabilize subtilisin BPN'. A list of unsuccessful attempts to engineer disulfide linkages in subtilisin by means outside the present embodiment of the current invention is given in Table 6.
Table 6
Geometry and Hαmology Parameters for Disulfide Bridge Sites that Failed to Stabilize Subtilisin BPN'
Effect Residues -Strain PMS Short Short Sequence0 on linked GX error I /C S/C CHI3 Homology Stability
A 1:S 78 7127 0.48 0 0 272 NC unchanged
A 1:S 78 II 0.54 0 0 252 II II
S 24:S 87 7123 0.51 2 1 270 NC unchanged
K 27:S 89 7136 0.71 1 1 239 K27 AC unchanged
A 85:A232 7122 0.73 - - 260 A85 AC decreased
A 85:A232 II 0.73 - - 83 II It
I122:V147 7115 0.83 - - 149 1122 AC decreased
S249:A273 7124 0.67 - - 294 A273 AC decreased
T253:A273 7140 0.29 — — 93 A273 & decreased T253 AC
T253:A273 _ 11 0.29 - - 226 11 II
°Ihe sequence hcroology is designated as nonconserved (NC) and absolutely conserved (AC) relative to the six sequences given in Table 4. Of the examples shown in Table 6, all except the 253/273 linkage have RMS values higher than 0.45. This linkage, which was introduced into subtilisin 7140, has two residues that are absolutely conserved in the six sequences given in Table 4. The decreased stability associated with this protein is believed to be due to altering important interactions that have been conserved throughout evolution. Four other proteins, subtilisin 7136, 7122, 7115, and 7124 also contain disulfide linkages that involve the alteration of a conserved residue, and all of these, except 7136, have also been found to have decreased stability relative to the wild- type protein. These proteins, however, also have the highest RMS errors, so the reason for the observed decreased stability is not so apparent in these cases. It could derive from a combination of a poor fit (RMS error) and alteration of a conserved interaction.
The two proteins that contain disulfide bridges that are not comprised of conserved residues are subtilisin 7127 and 7123. These linkages also do not have too bad a fit (RMS error of 0.48 and 0.51, respectively) . Both proteins were found to have stabilities close to that of the wild-type protein. The. failure of the 24/87 linkage to stabilize subtilisin 7123 may be related to the poor short contacts noted in the table. The 1/78 linkage is complex because of the relatively high accessibility of the N-terminus. Complex thiol chemistry which included intermolecular crosslinking was found to occur for subtilisin 7127.
This invention is intended to be useful for the stabilization of many different kinds of proteins under sundry conditions. For example, the redesigned subtilisin BPN', described herein, has been used as an active ingredient in detergent formulations for the enhancement of detergent performance. Subtilisin-like proteases are currently used in detergent formulations to improve the removal of protein stains such as blood and milk from soiled fabrics or garments. These detergent formulations can often present conditions of pH, temperature, free metal ion concentrations, and detergent content (hydrophobicity) that do not favor the properly folded state of enzymes, i.e., subtilisin-like proteases. Therefore, the present invention provides protein enzymes of enhanced stability that may be used in these applications.
While the invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications and this application is intended to cover any variations, ' uses, or adaptations of the .invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features hereinbefore set forth is as follows in the scope of the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A method for evaluating a protein's structure to determine whether said protein contains at least two target amino acid residues, the replacement of at least one of which with a cysteine residue would be sufficient to permit the formation of at least one potentially protein-stabilizing disulfide bond; said method comprising the steps of:
(a) comparing the distance between the centers-of-mass of two candidate target amino acid residues with the distance between the centers-of-mass of the cysteine residues of a disulfide bond;
(b) calculating the error obtained when a known disulfide bond is superimposed on said two candidate target amino acid residues; and
(c) using said comparisons (a) and (b) to determine whether said protein contains said at least two target amino acid residues, the replacement of at least one of which with a cysteine residue is sufficient to permit the formation of a potentially protein- stabilizing disulfide bond.
2. A method for producing a protein having a potentially protein-stabilizing disulfide bond which comprises:
(a) using the method of claim 1 to identify at least one target amino acid residue of said protein which could be replaced by a cysteine residue thereby permitting the formation of a potentially protein- stabilizing disulfide bond, and
(b) producing a protein molecule wherein said identified target amino acid residue has been replaced with a cysteine residue, said replacement permitting the formation of said potentially protein-stabilizing disulfide bond.
3. A method for producing a protein having a potentially protein-stabilizing disulfide bond which comprises:
(a) using the method of claim 1 to identify at least one target amino acid residue of said protein which could be replaced by a cysteine residue thereby permitting the formation of a potentially protein- stabilizing disulfide bond,
(b) producing a protein molecule wherein said identified target amino acid residue has been replaced with a cysteine residue, said replacement permitting the formation of said potentially protein-stabilizing disulfide bond, and
(c) forming the disulfide bond.
4. A method for producing a protein having a potentially protein-stabilizing disulfide bond which comprises:
(a) using a computer based method to evaluate said protein's structure to determine whether said protein contains at least two target amino acid residues, the replacement of at least one of which with a cysteine residue would be sufficient to permit the formation of at least one potentially protein- stabilizing disulfide bridge; said method comprising the steps:
(1) examining each selected pair of amino acids in said protein to determine if they contain certain atoms whose relative three-dimensional positions
/ possess a geometric conformation similar to the corresponding atoms of a known disulfide bridge,
(2) examining any pair of amino acids found to contain said certain atoms identified in step (1) to determine whether the new atoms of a possible disulfide linkage can be accommodated without creating unacceptable steric hindrance,
(3) permitting an expert operator (i) to view any possible disulfide linkage which can be accommodated without altering the tertiary conformation of said protein molecule, and (ii) to rank said viewed possible disulfide linkages from most likely to stabilize an engineered protein, to least likely to stabilize said protein, and
(4) evaluating said ranked proteins according to expert rule criterion; and
(b) producing a protein molecule wherein at least one of said target amino acid residues has been replaced by a cysteine residue, said replacement permitting the formation of a potentially protein- stabilizing disulfide bond.
5. The method of claim 4 wherein said expert rule criteria of step (4) comprises the steps:
(a) evaluating a possible disulfide linkage to determine whether formation of said linkage would require the loss of an evolutionally conserved amino acid residue; or
(b) evaluating a possible disulfide linkage to determine whether formation of said linkage would result in the loss of a favorable hydrophobic interaction.
6. A protein of increased stability produced by the method of claim 4.
7. The protein of claim 6 wherein said protein is selected from the group consisting of an enzyme and a binding protein.
8. The protein of claim 7 wherein said protein is an enzyme.
9. The enzyme of claim 8 wherein said enzyme is a protease.
10.. The protease of claim 9 wherein said protease is subtilisin.
11. The subtilisin of claim 10 wherein said subtilisin is selected from the group consisting of subtilisin 7159, subtilisin 8307, subtilisin 7181, and subtilisin 8310.
12. The subtilisin of claim 10 wherein said subtilisin contains at least one disulfide bond selected from the group consisting of:
(a) a disulfide bond between residues 22 and 87; and
(b) a disulfide bond between residues 206 and 216.
13. The protease of claim 9 wherein said protease is a serine protease homologous to subtilisin.
14. The protease of claim 13 wherein said protease contains at least one disulfide bond at a position determined by:
(a) obtaining the amino acid sequence of said protease;
(b) aligning the amino acid sequence of said protease with the amino acid sequence of subtilisin to maximize amino acid homology; and
(c) determining the position of said disulfide bond by identifying amino acid positions of said protein which have a geometry similar to at least one disulfide bond selected from the group consisting of:
(i) a disulfide bond between residues 22 and 87 of said subtilisin; or
(ii) a disulfide bond between residues 206 and 216 of said subtilisin.
15. The protein of claim 7 wherein said protein is a binding protein.
16. The binding protein of claim 15 wherein said binding protein is a DNA binding protein.
17. The binding protein of claim 15 wherein said binding protein is selected from the group consisting of receptor binding proteins, hormone binding proteins, antigen binding proteins and hapten binding proteins.
18. A nucleic acid sequence which encodes the protein of claim 6.
19. The nucleic acid of claim 18 wherein said nucleic acid is DNA.
20. The nucleic acid of claim 18 wherein said nucleic acid is RNA.
21. A nucleic acid sequence which encodes the enzyme of claim 8.
22. A nucleic acid sequence which encodes the protease of claim 9.
23. A nucleic acid sequence which encodes the subtilisin of claim 10.
24. A nucleic acid sequence which encodes the subtilisin of claim 11.
25. A nucleic acid sequence which encodes the binding protein of claim 15.
26. A nucleic acid sequence which encodes the binding protein of claim 16.
27. A nucleic acid sequence which encodes the binding protein of claim 17.
28. A method for improving the removal of proteinaceous stains on fabric comprising adding the subtilisin of any one of claims 10-12 to a washing preparation and cleaning said stained fabric with said washing preparation.
PCT/US1988/000849 1987-04-06 1988-03-18 Computer designed stabilized proteins and method for producing same WO1988008164A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US034,964 1987-04-06
US07/034,964 US4908773A (en) 1987-04-06 1987-04-06 Computer designed stabilized proteins and method for producing same

Publications (1)

Publication Number Publication Date
WO1988008164A1 true WO1988008164A1 (en) 1988-10-20

Family

ID=21879766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/000849 WO1988008164A1 (en) 1987-04-06 1988-03-18 Computer designed stabilized proteins and method for producing same

Country Status (2)

Country Link
US (1) US4908773A (en)
WO (1) WO1988008164A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340735A (en) * 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
WO1994024270A2 (en) * 1993-04-08 1994-10-27 National Research Council Of Canada Stable mutants of a low molecular mass xylanase
WO1996009396A1 (en) * 1994-09-20 1996-03-28 University Of Maryland Calcium free subtilisin mutants
US5665587A (en) * 1989-06-26 1997-09-09 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
WO1998020116A1 (en) 1996-11-04 1998-05-14 Novo Nordisk A/S Subtilase variants and compositions
US6566115B1 (en) 1999-07-22 2003-05-20 The Procter & Gamble Company Protease conjugates having sterically protected clip sites
US6586223B1 (en) 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6586224B1 (en) 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869620A (en) * 1986-09-02 1999-02-09 Enzon, Inc. Multivalent antigen-binding proteins
US5260203A (en) * 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US7413537B2 (en) * 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
IE911347A1 (en) * 1990-04-24 1991-11-06 Scripps Clinic Res System and method for determining three-dimensional¹structures of proteins
US5265030A (en) * 1990-04-24 1993-11-23 Scripps Clinic And Research Foundation System and method for determining three-dimensional structures of proteins
US5995908A (en) * 1990-09-20 1999-11-30 Margaret I. Pullen Integrated field modeling system
WO1992006191A1 (en) * 1990-09-28 1992-04-16 Protein Engineering Corporation Proteinaceous anti-dental plaque agents
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
US5331573A (en) * 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US5260882A (en) * 1991-01-02 1993-11-09 Rohm And Haas Company Process for the estimation of physical and chemical properties of a proposed polymeric or copolymeric substance or material
CA2105300C (en) * 1991-03-01 2008-12-23 Robert C. Ladner Process for the development of binding mini-proteins
AU2408292A (en) * 1991-07-11 1993-02-11 Regents Of The University Of California, The A method to identify protein sequences that fold into a known three-dimensional structure
US6025165A (en) * 1991-11-25 2000-02-15 Enzon, Inc. Methods for producing multivalent antigen-binding proteins
WO1993014465A1 (en) * 1992-01-21 1993-07-22 The Board Of Trustees Of The Leland Stanford Jr. University Prediction of the conformation and stability of macromolecular structures
US5241470A (en) * 1992-01-21 1993-08-31 The Board Of Trustees Of The Leland Stanford University Prediction of protein side-chain conformation by packing optimization
US5642292A (en) * 1992-03-27 1997-06-24 Akiko Itai Methods for searching stable docking models of biopolymer-ligand molecule complex
JPH08507916A (en) 1992-06-09 1996-08-27 カイロン コーポレイション Crystallization of M-CSF
DE69333422T2 (en) * 1992-07-31 2004-12-16 International Business Machines Corp. Finding strings in a database of strings
US5556749A (en) * 1992-11-12 1996-09-17 Hitachi Chemical Research Center, Inc. Oligoprobe designstation: a computerized method for designing optimal DNA probes
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US5581476A (en) * 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US5884230A (en) * 1993-04-28 1999-03-16 Immunex Corporation Method and system for protein modeling
US5453937A (en) * 1993-04-28 1995-09-26 Immunex Corporation Method and system for protein modeling
US5434796A (en) * 1993-06-30 1995-07-18 Daylight Chemical Information Systems, Inc. Method and apparatus for designing molecules with desired properties by evolving successive populations
US6436690B1 (en) * 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US6440717B1 (en) 1993-09-15 2002-08-27 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis
US5495423A (en) * 1993-10-25 1996-02-27 Trustees Of Boston University General strategy for vaccine and drug design
US6599730B1 (en) 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties
US5763733A (en) * 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
US6455295B1 (en) 1995-03-08 2002-09-24 The Procter & Gamble Company Subtilisin Carlsberg variants having decreased adsorption and increased hydrolysis
IL117350A0 (en) 1995-03-09 1996-07-23 Procter & Gamble Proteinase k variants having decreased adsorption and increased hydrolysis
US6475765B1 (en) 1995-03-09 2002-11-05 Procter & Gamble Company Subtilisin DY variants having decreased adsorption and increased hydrolysis
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5795761A (en) * 1996-01-11 1998-08-18 Rutgers, The State University Of New Jersey Mutants of 2,5-diketo-D-gluconic acid (2,5-DKG) reductase A
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
ATE364629T1 (en) 1996-01-22 2007-07-15 Curis Inc METHODS FOR PRODUCING OP-1 MORPHOGEN ANALOGUES
US6946280B1 (en) * 1996-03-29 2005-09-20 Genencor International, Inc. Enzyme multimer and process of producing same
US6453246B1 (en) 1996-11-04 2002-09-17 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing proximity data in a multi-dimensional space
US6571227B1 (en) 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
IL129728A0 (en) * 1996-11-04 2000-02-29 Dimensional Pharm Inc System method and computer program product for the visualization and interactive processing and analysis of chemical data
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
MA25044A1 (en) * 1997-10-23 2000-10-01 Procter & Gamble WASHING COMPOSITIONS CONTAINING MULTISUBSTITUTED PROTEASE VARIANTS.
US6978036B2 (en) * 1998-07-31 2005-12-20 Digimarc Corporation Tamper-resistant authentication techniques for identification documents
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
US6646110B2 (en) * 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
US6831158B2 (en) * 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US7416524B1 (en) 2000-02-18 2008-08-26 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. System, method and computer program product for fast and efficient searching of large chemical libraries
WO2001065462A2 (en) 2000-02-29 2001-09-07 3-Dimensional Pharmaceuticals, Inc. Method and computer program product for designing combinatorial arrays
WO2001071624A1 (en) 2000-03-22 2001-09-27 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing object relationships in a multidimensional space
WO2001075790A2 (en) 2000-04-03 2001-10-11 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for representing object relationships in a multidimensional space
JP2004507821A (en) * 2000-08-22 2004-03-11 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド Methods, systems and computer program products for determining characteristics of combinatorial library products from features of library building blocks
US6541234B1 (en) * 2000-09-11 2003-04-01 University Of Maryland Biotechnology Institute Calcium free subtilisin mutants
US6678619B2 (en) * 2000-09-20 2004-01-13 Victor S. Lobanov Method, system, and computer program product for encoding and building products of a virtual combinatorial library
US6541235B1 (en) * 2000-09-29 2003-04-01 University Of Maryland Biotechnology Institute Calcium free subtilisin mutants
WO2002061419A1 (en) * 2001-01-29 2002-08-08 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for analyzing combinatorial libraries
CA2440467A1 (en) * 2001-03-12 2002-09-19 Board Of Regents, University Of Texas System Ensemble-based strategy for the design of protein pharmaceuticals
WO2002073193A1 (en) * 2001-03-12 2002-09-19 Board Of Regents, The University Of Texas System Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis
US20030013137A1 (en) * 2001-03-13 2003-01-16 Barak Larry S. Automated methods of detecting receptor activity
US7244600B2 (en) * 2001-03-13 2007-07-17 Ultizyme International Ltd. Glucose dehydrogenase
AU2002325819B2 (en) * 2001-07-11 2008-06-19 Maxygen, Inc. G-CSF Conjugates
WO2003051174A2 (en) * 2001-11-09 2003-06-26 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
US20040067512A1 (en) * 2001-11-09 2004-04-08 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
EP1530631B1 (en) * 2002-01-16 2013-08-07 Genencor International, Inc. Multiply-substituted protease variants
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
WO2003100002A2 (en) * 2002-05-23 2003-12-04 Board Of Regents, The University Of Texas System Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
AU2003239783A1 (en) * 2002-06-26 2004-01-19 Novozymes A/S Subtilases and subtilase variants having altered immunogenicity
EP1558737A4 (en) 2002-10-18 2008-06-11 Lg Life Sciences Ltd Gene families associated with cancers
US20040093164A1 (en) * 2002-11-08 2004-05-13 Carlson William D. Computer system and methods for producing morphogen analogs of human TDF-1
US20090060933A1 (en) * 2004-06-14 2009-03-05 Estell David A Proteases producing an altered immunogenic response and methods of making and using the same
BRPI0611221A2 (en) 2005-06-01 2010-08-24 Maxygen Holdings Ltd pegylated g-csf polypeptides and their production methods
KR100954322B1 (en) 2006-06-14 2010-04-21 주식회사 엘지생명과학 Gene familyLBFL313 associated with pancreatic cancer
WO2009009493A2 (en) 2007-07-09 2009-01-15 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTEMENT OF HEALTH AND HUMAN SERVICES Aegyptin and uses thereof
US9244074B2 (en) 2011-06-07 2016-01-26 University Of Hawaii Biomarker of asbestos exposure and mesothelioma
WO2012170742A2 (en) 2011-06-07 2012-12-13 University Of Hawaii Treatment and prevention of cancer with hmgb1 antagonists
JP6366374B2 (en) * 2013-08-30 2018-08-01 キヤノン株式会社 Focus detection apparatus and control method thereof
CN116434828B (en) * 2023-04-17 2024-03-26 深圳新锐基因科技有限公司 Method and device for introducing dynamic disulfide bonds of protein molecules based on computational structure biology

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668476A (en) * 1984-03-23 1987-05-26 Applied Biosystems, Inc. Automated polypeptide synthesis apparatus
US4704692A (en) * 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4719582A (en) * 1983-11-16 1988-01-12 Ube Industries, Ltd. Method and apparatus for determining the chemical structure of an unknown substance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2286443A1 (en) * 1974-09-16 1976-04-23 Anvar APPARATUS FOR SIMULTANEOUS CODING AND VISUALIZATION OF A GRAPH
FR2426292A1 (en) * 1978-05-18 1979-12-14 Thomson Csf GRAPHIC TERMINAL PROCESSOR
US4414629A (en) * 1979-04-02 1983-11-08 Waite John H Method and apparatus for making correlations and predictions using a finite field of data of unorganized and/or partially structured elements
US4760025A (en) * 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
NZ208612A (en) * 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
EP0155832A3 (en) * 1984-03-16 1987-08-19 Genentech, Inc. Stable proteins, methods for their construction, plasmids and other dna encoding them, cell cultures harboring such plasmids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719582A (en) * 1983-11-16 1988-01-12 Ube Industries, Ltd. Method and apparatus for determining the chemical structure of an unknown substance
US4668476A (en) * 1984-03-23 1987-05-26 Applied Biosystems, Inc. Automated polypeptide synthesis apparatus
US4704692A (en) * 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197567B1 (en) 1989-06-26 2001-03-06 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
US5665587A (en) * 1989-06-26 1997-09-09 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
US7189553B2 (en) 1989-06-26 2007-03-13 Novozymes A/S Modified subtilisins and detergent, compositions containing same
US5340735A (en) * 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
WO1994024270A2 (en) * 1993-04-08 1994-10-27 National Research Council Of Canada Stable mutants of a low molecular mass xylanase
WO1994024270A3 (en) * 1993-04-08 1994-12-22 Ca Nat Research Council Stable mutants of a low molecular mass xylanase
WO1996009396A1 (en) * 1994-09-20 1996-03-28 University Of Maryland Calcium free subtilisin mutants
WO1998020116A1 (en) 1996-11-04 1998-05-14 Novo Nordisk A/S Subtilase variants and compositions
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6566115B1 (en) 1999-07-22 2003-05-20 The Procter & Gamble Company Protease conjugates having sterically protected clip sites
US6586223B1 (en) 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6586224B1 (en) 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions

Also Published As

Publication number Publication date
US4908773A (en) 1990-03-13

Similar Documents

Publication Publication Date Title
WO1988008164A1 (en) Computer designed stabilized proteins and method for producing same
US4853871A (en) Computer-based method for designing stablized proteins
US5340735A (en) Bacillus lentus alkaline protease variants with increased stability
Abad‐Zapatero et al. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents
Eklund et al. Structural and functional relations among thioredoxins of different species
Shortle Mutational studies of protein structures and their stabilities
US5260207A (en) Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins
Thornton et al. Analysis, design and modification of loop regions in proteins
Word et al. Exploring steric constraints on protein mutations using MAGE/PROBE
EP0916732A1 (en) The engineering of electronic interactions at metal ion binding sites for the stabilization of proteins
EP0409892A4 (en) Combining mutations for stabilization of subtilisin
JPH10506277A (en) Calcium-free subtilisin mutant
JP2007521823A (en) Protease variant
Fabry et al. Nucleotide sequence of the glyceraldehyde‐3‐phosphate dehydrogenase gene from the mesophilic methanogenic archaebacteria Methanobacterium bryantii and Methanobacterium formicicum: Comparison with the respective gene structure of the closely related extreme thermophile Methanothermus fervidus
Labean et al. Design of synthetic gene libraries encoding random sequence proteins with desired ensemble characteristics
Brandstetter et al. Mutational and structural analyses of the regulatory protein B of soluble methane monooxygenase from Methylococcus capsulatus (Bath)
Tsuji et al. Mutagenic analysis of the interior packing of an. alpha./. beta. barrel protein. Effects on the stabilities and rates of interconversion of the native and partially folded forms of the. alpha. subunit of tryptophan synthase
Rastetter Enzyme engineering: applications and promise
Aehle et al. Rational protein engineering and industrial application: structure prediction by homology and rational design of protein-variants with improved ‘washing performance’—the alkaline protease from Bacillus alcalophilus
Bech et al. Inactivation of carboxypeptidase Y by mutational removal of the putative essential histidyl residue
Blundell et al. Three-dimensional structural aspects of the design of new protein molecules
Wampler et al. Modeling the structure of pyrococcus furiosus rubredoxin by homology to other X‐ray structures
Lee et al. The active site of carboxypeptidase Taq possesses the active-site motif His–Glu–X–X-His of zinc-dependent endopeptidases and aminopeptidases
US7751987B1 (en) Method and system for predicting amino acid sequences compatible with a specified three dimensional structure
Pickersgill et al. Modification of the stability of phospholipase A2 by charge engineering

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): DK JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE